Annual Report 2011 - The University of Chicago Medicine

Transcription

today’s Science …
tomorrow’s
Standard of Care
2 0 1 0 – 2 0 11 A n n u a l R e p o r t
At t h e F o r e f ro n t o f D i s c ov e ry®
A
UCCCC 2010-2011 Annual Report
CONTENTS
A Message from the Director 1
Excellence in Science Translates
to Excellence in Care
2
+ Grants Fund Groundbreaking Research Opportunities
+ Top-Notch Technology Advances
Basic and Clinical Science
+ More Patients Have Access to UChicago Cancer Care
+ Expanded Community Outreach Efforts Help Underserved Chicagoans
Report from the Cancer Registry
16
+ Cancer Program Recognized for Quality, Innovation, and Excellence
+ A Focus on Leukemia
The University of Chicago Cancer
Research Foundation
24
+ Commitment to Cancer Research Remains Steadfast
+ Foundation Again Raises Over $2 Million for Cancer Research
+ UCCRF Boards
+ Honor Roll of Donors
+ Financial Report
A Look Ahead
40
The University of Chicago
Comprehensive Cancer Center (UCCCC)
is one of 40 National Cancer Institute
(NCI)-designated Comprehensive Cancer
Centers and one of two in Illinois.
The NCI designation recognizes scientific
excellence, as well as discovery and
development of effective approaches
to cancer risk assessment, prevention,
diagnosis, treatment, and survivorship.
The designation also recognizes a
cancer center’s accomplishments in
educating healthcare professionals
and the public, as well as its outreach
to underserved populations.
At the UCCCC, we have earned a
national and international reputation
of quality, innovation, and commitment
to addressing cancer from every angle.
B
cancer.uchicago.edu
A Message from the Director
Reflecting upon this past year, we
have seen much progress in our
efforts to develop personalized
cancer treatments that not only
target a patient’s genetic makeup,
but also target a tumor’s genetics
and behavior. This individualized
approach provides better outcomes
and economic efficiency.
As treatments become even more customized
early 1970s made leukemia the first cancer
and individualized, cancer research will become
for which personalized therapeutics became
more diversified and collaborative, requiring a
possible. Today, our work in leukemia continues
global team of experts capable of understanding
to foster the development of novel therapies.
cellular processes at a much finer level. Cancer
researchers will work more closely with physicists,
chemists, and biostatisticians who can analyze
very large, complex data arrays. Researchers will
also collaborate with economists who will help
us understand the economic impact of cancer.
Although much of our financial support comes
from external sources including the National
Institutes of Health and the American Cancer
Society, another large portion comes from
passionate philanthropists. We sincerely thank
all of our donors who have provided the seed
The new UCCCC strategic plan acknowledges
money and other support that have resulted in
our strengths in the scientific and clinical arenas
much larger government grants, as well as new
and takes into account the changing landscape
program development and faculty recruitment.
of cancer research. Our goals over the next
few years will focus on three key areas:
++ Cancer risk assessment and prevention
With 12 million cancer survivors in the
United States, it is imperative that we remain
diligent in our commitment to excellence
++ Individualized therapies
and innovation so that today’s science can
++ Cancer survivorship, economics, and outcomes
become tomorrow’s standard of care.
As you read the following pages, you will
get a glimpse at some of the very exciting
With heartfelt gratitude,
advancements that we have made this past fiscal
year. You will also learn about new programs and
partnerships that will make our superior cancer
care available to an even wider audience.
This year, we dedicated a portion of our annual
report to the Leukemia Program (See Page
19). Groundbreaking work at UChicago in the
1
Michelle M. Le Beau, PhD
Arthur and Marian Edelstein Professor of Medicine
UCCCC Director
Excellence in Science
Translates to Excellence in Care
This year, our annual report focuses on how our efforts
transform today’s science into tomorrow’s standard of care.
Utilizing the collective expertise of 225 members
from six integrated scientific programs, the
UCCCC focuses on understanding the many
complex issues related to cancer risk, prevention, diagnosis, treatment, and survivorship.
Personalized medicine is a primary focus of the
UCCCC. One day, physicians will be able to use
a series of markers unique to each person to
tailor individualized prevention and treatment
strategies. These markers could include genetic,
social, environmental, and behavioral factors.
Center for Personalized Therapeutics
Some personalized treatments already exist
in oncology. They include genetic tests and
protein measurements to identify the appropriate treatment strategies for patients with
breast, lung, and colorectal cancer.
Mitchell Posner, MD
Peter O’Donnell, MD
Ya-Chen Tina Shih, PhD
In 2010, The University of Chicago (UChicago)
opened a Center for Personalized Therapeutics,
directed by Mark Ratain, MD, the Leon O. Jacobson
Professor of Medicine and UCCCC associate
director for clinical sciences. The center is now
recruiting patients in a first-of-its-kind study that
incorporates broad genetic information into routine
clinical practice for medical treatment decisions.
Such information could allow physicians to predict
which patients are most likely to respond positively to a given medication, experience severe
side effects, or require alternative dosing.
The study, named “The 1200 Patients Project,” is
led by Peter O’Donnell, MD, assistant professor
of medicine. The new project complements
work by the UChicago Committee on Clinical
Pharmacology and Pharmacogenomics, chaired
by M. Eileen Dolan, PhD, professor of medicine.
Pharmacogenomics is the study of how genetic
variants affect a patient’s response to drugs.
2
Initiative in Economics of Cancer
Another first-of-its-kind program is the new
Initiative in the Economics of Cancer, led by
Ya-Chen Tina Shih, PhD, associate professor
of medicine. By uniting cancer researchers
with experts from the social sciences, Dr.
Shih’s group aims to weigh the costs and
benefits of new technologies so that patients
receive the best, most logical care.
“The burden of cancer and cost of cancer care
are among the most important challenges facing
the U.S.,” said David Meltzer, MD, PhD, associate
professor of medicine and director of the Center for
Health and the Social Sciences. “The University of
Chicago’s strength in economics and cancer and its
rich tradition of interdisciplinary research make it
an ideal place for the development of this program.”
Patient Navigation Program
To help facilitate the sometimes intimidating
task of coordinating initial appointments
with multiple specialists, The University of
Chicago Medical Center (UCMC) launched
the Central Intake and Navigation program
in early 2011 for its cancer patients.
“Our patients deserve an efficient system in which
they can learn about their disease, understand
it, review their options, and develop a plan,” said
Mitchell Posner, MD, Thomas D. Jones Professor
and Vice-Chair of Surgery. “For many patients,
a cancer diagnosis is a life-defining moment.”
The program quickly produced positive results.
The average wait time for appointments decreased
from 13.8 calendar days at the beginning of the
fiscal year to 10.1 calendar days by summer
2011, with a significant movement toward
appointments in 7 days or less by fall of 2011.
cancer.uchicago.edu
Personalized medicine is a primary focus of the UCCCC. One day,
physicians will be able to use a series of markers unique to each
person to tailor individualized prevention and treatment strategies.
Grants Fund Groundbreaking
Research Opportunities
Before cancer treatment options ever reach
the clinic, UCCCC researchers spend months—
or more likely years—analyzing many intricate
details about a cancer’s biology and behavior.
are studying how transfer RNAs work as biomarkers
and regulators of gene expression in breast cancer.
The science needed to stimulate significant
transformation from bench to bedside requires
a significant investment. New discoveries would
not be possible without grants from the government, industry, and the private sector.
Computer-Aided Diagnosis of Prostate
Cancer with Multiparametric MR Imaging
Aytekin Oto, MD, associate professor of radiology, and his research team are developing a
pilot computer-aided diagnosis (CAD) system
for detecting prostate cancer using magnetic
resonance (MR) imaging. This new method will
provide a noninvasive way to differentiate between
high-risk and low-risk prostate cancers and will
help standardize the analysis of MR results. With
these advantages, the CAD/MR imaging technology may help more than a million American
men who undergo prostate biopsies each year.
This fiscal year, our investigators were involved
with more than 600 funded projects totaling about
$110 million. The projects were supported through
grants from the National Institutes of Health (NIH)
and its institutes, including the National Cancer
Institute (NCI), as well as the American Cancer
Society (ACS), The University of Chicago Cancer
Research Foundation (UCCRF), Cancer Research
Foundation (CRF), and other private foundations.
The following grant projects were among
those funded in fiscal year 2010-2011:
Synergy of Radiation and
Immunotherapy: New Approaches
Transfer RNAs as Biomarkers and Regulators
of Gene Expression in Breast Cancer
Marsha Rosner, PhD, director and Charles B.
Huggins Professor of the Ben May Department for
Cancer Research, and colleagues are conducting
genomic research to identify the key genes responsible for forming breast cancer. In particular, they
Aytekin Oto, MD
Maciej Lesniak, MD
4
Marsha Rosner, PhD
Yang-Xin Fu, MD, PhD, professor of pathology,
and colleagues are establishing new strategies
to reduce original tumor size while boosting
immunity for the destruction of cancer cells
that have spread to other parts of the body. By
studying the underlying workings of the immune
system, the researchers aim to develop a novel,
Marc Bissonnette, MD
cancer.uchicago.edu
Yang-Xin Fu, MD, PhD
New discoveries would not be possible
without grants from the government,
industry, and the private sector.
(Left) Patrick Wilson, PhD, MS
highly effective treatment approach combining
radiation therapy with immunotherapy for
various phases of cancer, including metastases.
EGFR-VDR Signals in Diet-Promoted
Inflammation and Cancer
Marc Bissonnette, MD, associate professor of medicine, and his research team are investigating the
connection between a Western-style, high-fat diet
and the development of colon cancer. Building on
previous research, the investigators aim to uncover
how the epidermal growth factor receptor (EGFR)
and vitamin D signaling pathways interact to affect
the influence of dietary fat on colonic inflammation
and tumor risk. These studies will identify potential
new therapeutic targets for colon cancer, the third
leading cause of cancer-related deaths in the U.S.
Neural Stem Cell-Based Virotherapy
for Malignant Glioma
Maciej Lesniak, MD, professor of surgery and
director of neurosurgical oncology and neurooncology research, and colleagues are developing a novel approach, called virotherapy, for
the treatment of malignant brain tumors. The
team will use neural stem cells to carry a virus,
specially developed to attack cancer cells, directly
to the malignant brain tumor. They hypothesize
that this targeted technique will be more effective than injecting the virus into the tumor.
A researcher works in the Le Beau hematology/oncology research lab in the Knapp Center for Biomedical Discovery.
6
cancer.uchicago.edu
Top-Notch Technology Advances
Basic and Clinical Science
To make cancer research more cost-efficient and
to help provide the most technologically advanced
equipment possible, the UCCCC offers researchers
access to shared technologies supported through
our NCI Cancer Center Support Grant.
The Core Facilities include 12 mature facilities
and one developing facility opened in 2011.
The new Epidemiology and Research
Recruitment Core (ERRC) provides expertise in study design, patient recruitment, and
data collection to help researchers more efficiently conduct studies to observe cancer
patterns within different patient populations.
“It’s kind of a ‘one-stop shop,’” said Scientific
Director Brian Chiu, PhD. “We coordinate systematic and rigorous specimen collection as well
as implement processes for large-scale collection of interview data to ascertain individual
variables and exposure history. The integration
of these multiple dimensions allows investigators to conduct high-quality multidisciplinary
population and clinical research studies.”
State-of-the-Art Technologies
Keeping up with advances in lab equipment,
software, and other technologies is extremely
important as cancer research delves deeper into
the complex study of cellular and molecular
mechanisms that contribute to tumor development.
“The best tools make for the best science,” said
Vytas Bindokas, PhD, co-technical director of
the Integrated Microscopy Core Facility.
Several of the core facilities received funding
this year to update or expand their offerings:
++ The Integrated Microscopy Core acquired
three new major systems that represent
the best in corrected optics, with advanced
features that allow for high speed and
sensitivity. Modern-day advanced optics help
solve new mysteries, including why some
cancer cells behave differently than others.
++ The Genomics Facility purchased new systems
to conduct next-generation sequencing with
the high-throughput capacity for genotyping
and gene expression arrays. These systems
offer the fastest technology available for
sequencing genetic information, which will
help researchers find associations between
specific gene variants and disease.
++ The Human Tissue Resource Facility has
implemented a new biospecimen banking
database and a new digital pathology image
analysis system to accelerate basic and
clinical research. The space itself will soon
undergo renovations to improve workflow and
allow for expanded storage of specimens.
Prototype Breast Imaging System
Innovative technologies have the potential to change medical practice.
A prototype breast imaging computer workstation, created by radiology professor Maryellen
Giger, PhD, and members of her research team,
could soon revolutionize the way breast cancer
is diagnosed. The intelligent breast workstation for computer-aided diagnosis (CADx)
and quantitative image analysis reviews data
from multimodality images and helps evaluate and characterize suspicious lesions.
Fused PET/CT image using radiotracers
that will soon be produced on campus.
Dr. Giger said she is excited to see the technology
move one step closer to clinical implementation,
“I see CADx translating to the clinical setting in
Test sample captured with a new highpowered light microscope.
7
Maryellen Giger, PhD, and her research team
created a prototype breast imaging computer
workstation that could revolutionize the way
breast cancer is diagnosed.
the near future as another ‘test result’ to be used
concurrently by radiologists in improving the accuracy of diagnostic output and patient management.”
only help to find more accurate ways to apply
radiation therapy, but will also allow researchers
to assess the effectiveness of gene therapy.
Cyclotron Particle Accelerator
The cyclotron purchase was made possible, in
part, by a 2011 donation from the William F.
O’Connor Foundation, named for a legendary
figure in Chicago financial circles who had a
strong personal belief in the quality of care at
UChicago. Our institution will be the only academic
medical center in Illinois with a cyclotron.
Research capabilities will be greatly enhanced
when a cyclotron is installed on campus in 2012.
A cyclotron is a particle accelerator that generates radioisotopes used in diagnostic imaging.
Imaging at the molecular level provides a noninvasive way to monitor and assess a patient’s
response to treatment. Radioisotopes will not
8
cancer.uchicago.edu
More Patients Have Access
to UChicago Cancer Care
The UCCCC, with its team of talented clinical and
laboratory scientists, is making great strides in helping
cancer patients live longer and lead better quality lives.
Very soon, this high level of cancer care
and expertise will reach even more patients
in a new state-of-the-art building.
Construction of the New Hospital Pavilion (NHP)
is expected to be completed in 2012, with the first
patients admitted in early 2013. The NHP is poised
to be one of the most leading-edge hospitals in the
world. The building’s flexible design will enhance
collaboration and interaction among physicians,
as well as allow the hospital to adapt easily to
new technologies. The 10-story, 1.2 millionsquare-foot building will span two city blocks and
will connect to Comer Children’s Hospital and
the outpatient Duchossois Center for Advanced
Medicine (DCAM). An entire floor will be devoted
exclusively to the care of cancer patients.
In spring 2012, another newly constructed cancer
facility will be unveiled, outside The University
of Chicago’s Hyde Park campus. The two-story
outpatient cancer treatment center will be
located about 39 miles southwest of downtown
Chicago in New Lenox, Ill., as part of a partnership
between the UCMC and Silver Cross Hospital.
The University of Chicago Cancer Center at
Silver Cross will offer academic medical center
specialists in a community hospital setting to
serve patients who normally would have to travel
far distances to obtain the cancer services they
The University of
Chicago Cancer
Center at Silver Cross
will open in 2012 in
New Lenox, Ill.
9
The New Hospital Pavilion will offer
240 private patient rooms, all on the
upper levels and each with a spectacular view of the city.
need. Patients will have access to physicians,
chemotherapy infusion services, radiation therapy,
cancer support groups, preventative screenings, and a comprehensive resource center. The
new center will also have a top-of-the-line linear
accelerator for image-guided radiation therapy that
provides the safest and most accurate results. Access to Cancer Clinical Trials
Silver Cross cancer patients will also have
access to cancer clinical trials. The UCCCC
has the largest cancer clinical trials program
in Illinois and is one of only a few institutions
in the country to provide all three phases of
clinical trials through NCI-funded programs.
In 2010, approximately 900 patients were enrolled
in cancer therapeutic trials. These trials focused
on the study of new drugs, stem-cell transplantation, and multidisciplinary treatments.
Patient enrollment is under way for more than
350 cancer clinical trials at the UCCCC. To see a
complete list, visit our new website, which was
launched in August 2010. Go to cancer.uchicago.
edu and click on Search Clinical Trials in the blue
box, or call toll-free 1-855-702-8222 for adult
trials or 1-773-702-6808 for pediatric trials.
Cancer Resource Center to Expand
The Cancer Resource Center (CRC) will get
a makeover later this year. The CRC, which
is a partnership between the UCCCC and the
ACS, is located on the first floor of DCAM.
Staffed by a licensed professional counselor and
a certified health education specialist, the CRC
10
provides cancer patients and their families with
information that helps make the treatment process
easier—everything from one-on-one counseling, to
access to cancer literature and cosmetic services.
In fiscal year 2010-2011, CRC staff met with nearly
3,000 patients, including 816 new patients.
“Most patients really need help with transportation and the financial burden it creates,” said
CRC Program Manager Mary P. Herbert, BSS,
CHES. “This past fiscal year, thanks to private
donations to ACS, we were able to provide those
in need with $37,000 in transportation assistance including parking passes, Chicago Transit
Authority passes, and Pace Paratransit Service
passes. We are one of only a few sites in the
country that provides this type of service.”
More than a dozen support groups are also offered,
including a new support group that was launched
in July 2011. The Cancer Networking Group for
Women of Color meets on the second Wednesday
of the month on the fourth floor of DCAM.
In 2012, the new CRC offices will be part of
a more spacious patient waiting area. The
larger footprint will allow for private waiting
spaces in an aesthetically pleasing, open
floor plan. Cancer patient navigators will be
located in the same area to help patients coordinate and streamline their experience.
“The private areas will help us do more oneon-one counseling and will make patients
more comfortable when they need services,
such as a wig fitting,” added Herbert.
cancer.uchicago.edu
Expanded Community
Outreach Efforts Help
Underserved Chicagoans
Encouraging people to live healthier lifestyles and
to understand the benefits of cancer screening are
two priorities for the UCCCC Office of Community
Engagement and Cancer Disparities (OCECD).
As the office celebrated its first anniversary in
August 2011 under the direction of Karen E. Kim,
MD, MS, it also marked substantial progress in
developing relationships with Chicago’s underserved communities—including the black, Asian,
Hispanic, and Native American communities.
OCECD staff met with more than 7,000
people this past fiscal year through 36 community events, ranging from national and regional
healthcare symposia, to family wellness nights,
to a Powwow at Navy Pier. Many cancer topics
were addressed, although the primary focus
for the office’s first year was breast cancer.
These relationships were strengthened through
strategic partnerships with various units
within UChicago, as well as with community- and faith-based organizations.
“One out of every three cancer diagnoses in
American women is breast cancer, and we’ve
found that the breast cancer death rate is much
11
Pritzker School of Medicine students
helped administer cancer screening
surveys and flu shots in the Asian
community in December 2010.
higher in Chicago than in New York City or in
the U.S. as a whole. We need to change that,”
said Dr. Kim, associate professor of medicine.
built an infrastructure to address the cancer
disparities facing Asian Americans,” said AHC
Executive Director Edwin Chandrasekar.
ENRICH’D Program
Community Health Educators
In early 2011, the OCECD launched the innovative Empowering Neighborhood Resources in
Combating Health Disparities (ENRICH’D™)
program, designed to increase awareness about
cancer screening, treatment, and access to healthcare resources. With input from The University
of Chicago Pritzker School of Medicine students,
as well as community members, programs are
adapted to the unique characteristics of each
neighborhood to help close gaps in healthcare
knowledge and encourage healthier lifestyles.
The Asian community is also benefitting from a
strategic partnership between the OCECD and the
Chinese American Service League (CASL). Using
resources from an NCI Cancer Center supplement grant for Community Health Educators,
several hundred homecare workers participated
in discussions—primarily in Cantonese—about
the benefits of breast cancer screening and the
resources that are available in the community.
“If you have community members who speak
the language and who look like the community,
they can deliver a very powerful message that
will motivate behavioral change,” said Dr. Kim.
ENRICH’D kicked off in the Roseland community, a predominantly black neighborhood on
Chicago’s South Side, and was highlighted
by a breast cancer forum held at the South
Shore Cultural Club in June. Nearly 200 people
attended, and more than 50 people registered for free mammography services.
ENRICH’D, funded in part by a grant from
Exelon Corporation, will expand this fall into
the Asian community in the Armour Square
neighborhood. A solid partnership with the
Asian Health Coalition (AHC) is helping to
increase participation in OCECD activities.
“Being a partner with the OCECD has been an
empowering experience. Under the leadership
of Dr. Kim, I am excited that the OCECD has
Karen E. Kim, MD, MS, hosts an ED-U-CATE
session at the Chinese American Service League.
12
ED-U-CATE Program
The OCECD is also offering a workplace wellness program designed to educate small groups
of employees about cancer risk, prevention,
screening, treatment options, and clinical trials.
The Everyone Developing an Understanding of
Cancer Awareness, Treatment, and Education
(ED-U-CATE) program launched in February
2011. By mid-year, the program was presented
to more than 150 people within UChicago,
CASL, Chicago Urban League, and PepsiCo.
In fall 2011, ED-U-CATE will be presented at
Catholic Charities and Chicago Public Schools.
Cancer Transitions Program
A grant from the LIVESTRONG™ foundation
helped the OCECD prepare to become one of
the nationwide hosts of Cancer Transitions™, a
program that helps cancer patients through the
transitional period following cancer treatment.
The program includes sessions on nutrition,
exercise, stress reduction, medical management, and quality of life. The first series began
in August 2011 on Chicago’s South Side.
Woodlawn Charter School students visited UChicago in March to learn
about careers in the medical field, including community outreach.
cancer.uchicago.edu
(Top) An outreach event in Chinatown provided participants with glaucoma and diabetes screenings, in addition to gathering data about cancer knowledge.
(Bottom left) Tanya Kimber from the American Cancer Society and Fornessa Randal from the UCCCC helped distribute cancer information during a breast cancer event.
(Bottom right) About 200 women attended a breast cancer forum at the South Shore Cultural Center.
13
UCCCC Welcomes 15 New Members
Our accomplishments this past year would not have been
possible without the 225 dedicated scientists and clinicians
composing the UCCCC cancer research team.
In fiscal year 2010-2011, we welcomed more than a dozen new members. They are:
14
Eric Svensson,
MD, PhD
Associate
Professor of
Medicine >
Peter
O’Donnell, MD
Instructor of
Medicine >
Victoria
Villaflor, MD
Assistant
Professor of
Medicine
<
Brandon
Pierce, PhD
Assistant
Professor of
Health Studies
<
Yoav Gilad, PhD
Associate Professor
of Human Genetics
(not pictured)
Joshua
Hemmerich,
PhD
Assistant
Professor of
Medicine >
Michael
Spiotto,
MD, PhD
Instructor of
Radiation
and Cellular
Oncology
<
Jennifer
McNeer, MD
Assistant
Professor of
Pediatrics
<
Daniel
Catenacci, MD
Instructor of
Medicine
<
Jill de Jong,
MD, PhD
Assistant Professor
of Pediatrics >
Ya-Chen Tina
Shih, PhD
Associate
Professor of
Medicine >
Vani Konda,
MD
Instructor of
Medicine >
Issam Awad,
MD, MSc
Professor of
Surgery >
Iris Romero,
MD
Assistant
Professor of
Obstetrics and
Gynecology >
Patrick Wilson,
PhD, MS
Assistant
Professor of
Medicine >
cancer.uchicago.edu
UCCCC Members
Earn National
Honors
The many honors—local, national,
and international—bestowed on
our scientists and clinicians reflect
the high caliber of their work
and the significant contributions
they are making to patient care.
The following is a small sample of their distinguished achievements:
Nancy Cox, PhD
Member-at-Large, Section on
Biological Sciences, American
Association for the Advancement
of Science (AAAS)
Thomas Gajewski, MD, PhD
President, Society for
Immunotherapy of Cancer (SITC)
Karen E. Kim, MD, MS
Member, NIH Advisory Committee
on Research on Women’s Health
Inaugural Arthur and Marian
Edelstein Professor of Medicine
Kay Macleod, PhD
Member, NIH Cancer Molecular
Pathobiology Study Section
15
Elizabeth McNally, MD, PhD
President, American Society for
Clinical Investigation (ASCI)
Mitchell Posner, MD
President, Society of Surgical
Oncology (SSO)
Bruce Minsky, MD
Educator of the Year, Association of
Residents in Radiation Oncology
(ARRO) / American Society for
Radiation Oncology (ASTRO)
Mark Ratain, MD
American College of Clinical
Pharmacology (ACCP)
Honorary Fellow Award
Olufunmilayo Olopade, MBBS
ACS Distinguished Service
Award and Member, National
Cancer Advisory Board
Xiaochuan Pan, PhD
Chair, NIH Biomedical Imaging
Technology Study Section
Carrie Rinker-Schaeffer, PhD
President, Metastasis
Research Society (MRS)
Mark Siegler, MD
American Society for Bioethics
and Humanities (ASBH)
Lifetime Achievement Award
Cancer Program Recognized for
Quality, Innovation, and Excellence
The University of Chicago Medical Center (UCMC)
cancer program gained ground in the 2011-2012 U.S.
News & World Report annual Best Hospitals survey.
The #14 ranking is one position higher than
the previous survey and keeps the UCMC as
the #1 ranked cancer program in Illinois. The
rankings are based on a mathematical formula
that takes into account factors including
expected mortality, actual mortality, technology, patient services, and patient volume.
The cancer program also earned a top accreditation from the American College of Surgeons
(ACoS) Commission on Cancer (CoC). The 3-year
accreditation with commendation symbolizes
excellence, innovation, and a broad spectrum
of cancer research and patient care services
offered locally, nationally, and internationally.
“We are honored to receive such a high rating,”
said UCCCC Director Michelle Le Beau, PhD.
“For our patients, this means they can expect to
receive quality, comprehensive care that includes
a multidisciplinary team approach, a complete
range of state-of-the-art services and treatments, and access to early detection programs,
cancer education, and support services.”
Led by Kevin Roggin, MD, chair of the Cancer
Committee, and assisted by Cassie Simon, CTR,
assistant director of the UCCCC Cancer Registry,
the cancer program underwent an intensive, onsite
CoC survey in May 2011. As part of this triennial process, members of the Cancer Committee
provided detailed information about their departmental resources, policies, and processes that
ensure high-quality, multidisciplinary, cancer
care is available and provided to our patients.
Our Cancer Program
received commendation
in seven key areas:
++Outcomes analysis
++Quality of National Cancer
Data Base (NCDB) data
submission
++College of American
Pathologists (CAP)
guidelines
++Clinical trials accrual
++Prevention and early
detection
++Cancer education for
registry staff
++Cancer-related quality
improvement
16
cancer.uchicago.edu
Table 1: 2010 Cancer Cases by Site
Primary Site
Newly
Diagnosed
Recurrent/
Progressive
Disease
Total
% of
Total
Digestive System
563
65
628
18.50%
Male Genital System
496
72
568
16.80%
Breast
308
38
346
10.20%
Respiratory System
286
47
333
9.80%
Urinary System
242
42
284
8.40%
Endocrine System*
173
25
198
5.80%
Female Genital System
149
28
177
5.20%
Oral Cavity & Pharynx
127
34
161
4.70%
Lymphoma
112
26
138
4.10%
Brain & Other Nervous System**
99
20
119
3.50%
Leukemia
97
28
125
3.70%
Miscellaneous***
59
10
69
2.00%
Skin Excluding Basal & Squamous
49
19
68
2.00%
Myeloma
43
5
48
1.40%
Soft Tissue
40
12
52
1.50%
Mesothelioma
40
7
47
1.40%
Bones & Joints
21
3
24
0.70%
Kaposi Sarcoma
3
0
3
0.10%
Eye & Orbit
1
2
3
0.10%
2,908
483
3,391
100.00%
Total
* Includes benign pituitary tumors
** Includes benign neoplasms
***Includes blood dyscrasias, myelodysplastic syndromes, and myeloproliferative disorders
Cancer Registry Provides
Vital Research Data
2010 UCMC Cancer Data
The Cancer Registry annually reviews more than
50,000 UCMC medical records to identify patients
diagnosed and/or treated for cancer or a benign
central nervous system neoplasm. A specialized
oncology database record is created for each
cancer patient that includes age, gender, diseasespecific characteristics, treatment, annual followup, and outcomes. An abstract or “snapshot” is
created for each patient’s disease experience.
In 2010, 3,391 patients were diagnosed and/or
treated at the UCMC for a malignancy or benign
central nervous system neoplasm. (See Table 1)
Throughout the year, the registry receives requests
from physicians, researchers, administrators, and
other medical staff for specific or aggregate data
that will be used to improve patient care—whether
it is to generate prevention strategies, to advance
technologies for screening, diagnosis, and treatment, or to develop survivorship programs.
In the past fiscal year, the Cancer Registry fulfilled
60 data requests for projects including clinical
research, health disparities research, outcomes
research, cancer program development, grant
proposals, and community outreach activities.
17
Cancer Incidence by Type
Of these, 2,908 (86%) were newly diagnosed patients and 483 (14%) had recurrent
or progressive disease. The most frequently
seen cancers were of the digestive system
(628), which includes colorectal cancer; male
genital system (568), which includes prostate cancer; breast (346); respiratory system
(333), which includes lung cancer; and urinary
system (284), which includes kidney cancer.
Patient Demographics
More than half of all patients (1858, 54.8%)
were diagnosed with cancer between the ages
of 50 and 69 years. When reviewing the data
by gender, women tended to be diagnosed
at a younger age than men (50–59 years vs.
60–69 years respectively). (See Figure 1)
Distribution by gender (See Figure 2) reveals a
higher number of male patients (1,849, 54.5%) than
female patients (1,542, 45.5%), and distribution by
race shows our patient population is predominately
white (2,103 patients, 62%), followed by black (871
patients, 25.6%) and Hispanic (146 patients, 4.3%).
Patient Geographics
An analysis of a patient’s residence or county at
initial diagnosis (See Diagram 1) illustrates that a
majority of patients (2,671, 79%) seen in 2010 were
Illinois residents, with the highest number residing
in Cook County (1,740 patients, 65.1%) followed by
DuPage County (244 patients, 9.1%), Will County
Figure 1: 2010 Cancer Cases by
Gender and Age at Diagnosis
(207 patients, 7.7%), Lake County (148 patients,
5.5%) and Kane County (59 patients, 2.2%).
Nearly one quarter (21%, 720 patients) of our total
cancer patient population lived outside of Illinois,
coming primarily from the neighboring states
of Indiana (550 patients, 76.3%), Michigan (56
patients, 7.7%), and Wisconsin (27 patients, 3.7%).
We also served 18 international patients from
countries including Israel (4 patients), Mexico
(3 patients), United Arab Emirates (3 patients),
China (2 patients), Brazil (1 patient), Canada (1
patient), Panama (1 patient), Poland (1 patient),
Romania (1 patient), and Saudi Arabia (1 patient).
Figure 2: 2010 Cancer Cases by
Gender, Race/Ethnicity
700
1,500
600
1,200
500
900
300
Number of cancer cases
Number of cancer cases
400
200
100
0
0-29
Male
30-39 40-49 50-59 60-69 70-79 80-89
90+
Female
600
300
0
White
Black
Male
Hispanic
Asian
Female
Asian Unknown
Indian or
Pakistani,
NOS
Diagram 1: 2010 Patient Residence at Diagnosis
Illinois Residents by County
Non-Illinois Residents
1,740 (65.1%)
Cook
550 (76.3%)
Indiana
59 (2.2%)
Kane
56 (7.7%)
Michigan
148 (5.5%)
Lake
2,671 (79%)
720 (21%)
27 (3.7%)
Wisconsin
207 (7.7%)
Will
18 (1%)
Outside of U.S.:
Israel, Mexico, United Arab
Emirates, China, Brazil, Canada,
Panama, Poland, Romania, and
Saudi Arabia
244 (9.1%)
DuPage
18
cancer.uchicago.edu
A Focus on Leukemia
As personalized medicine moves within reach in
many specialties, leukemia was the first cancer
for which personalized therapeutics became
possible—and it has its roots at UChicago.
Pioneering work by scientists including Janet D.
Rowley, MD, DSc, James W. Vardiman, MD, Harvey
M. Golomb, MD, Richard A. Larson, MD, Michelle
M. Le Beau, PhD, and Michael J. Thirman, MD,
helped uncover the biology and heterogeneity
of leukemias that paved the way for biologically
targeted treatments, including tyrosine kinase
inhibitors (e.g., imantinib, nilotinib, dasatinib),
which are now standard treatment for chronic
myeloid leukemia (CML). Dr. Larson was a key
investigator in the pivotal clinical trials that led
to approval of these groundbreaking therapies.
The seminal event came in 1972 when Dr. Rowley
discovered that some forms of leukemia are triggered by a translocation of two different chromosomes. This breakthrough confirmed a genetic basis
for cancer and earned Dr. Rowley countless awards,
including the prestigious Lasker-DeBakey for
Clinical Medical Research Award, National Medal
of Science, and Presidential Medal of Freedom.
Current Highlights
Since Dr. Rowley’s breakthrough, the leukemia
group at UChicago has continued to characterize
genetic changes for several key forms of acute
and chronic leukemia, providing insights that are
leading to the development of novel therapies. For
example, Dr. Le Beau is currently the principal
investigator of a project involving Dr. Larson, Kenan
Onel, MD, PhD, and others to understand more
about the development of therapy-related myeloid
neoplasms—leukemias that develop as a result of
successful chemotherapy or radiotherapy for other
malignancies, such as lymphoma or breast cancer.
“During the past decade, we have learned a
great deal about the dysregulation of genes
that are involved in various leukemias. We have
also learned, in many cases, which patients will
19
respond well to certain treatments and which
patients will not,” explained Wendy Stock,
MD, professor of medicine and co-leader, with
Dr. Thirman, of the UCCCC Hematopoiesis
and Hematological Malignancies Program.
One area of current interest to the UChicago
leukemia group is the study of epigenetic modifications and abnormalities that occur in leukemia.
Epigenetic studies examine factors, such as
abnormal DNA methylation and structural modifications in chromatin, that deregulate normal
gene expression and promote cancer development. Lucy Godley, MD, PhD, Olatoyosi Odenike,
MD, and colleagues are trying to understand what
causes epigenetic dysregulation in acute myeloid
leukemia (AML) and related malignancies, and
they are working to develop therapies to reprogram
abnormal gene expression in malignant cells. Based
on these insights, our leukemia clinicians have
designed novel clinical trials to evaluate the efficacy
of these approaches for patients with leukemias
that are resistant to more traditional chemotherapy.
Improving cure rates using hematopoietic
cell transplantation is another important
research focus. Andrew Artz, MD, and Amittha
Wickrema, PhD, are working to improve access
to this curative approach for a broader range
of patients—those who are older, who may not
have a traditional sibling donor, and for those
with high-risk biological features who might not
otherwise be eligible to receive a transplant.
Along with new faculty recruit Hongtao Liu, MD,
PhD, the leukemia transplant group has recently
completed a novel study demonstrating the
feasibility of using hematopoietic cells from an
immunologically half-matched donor combined
with an umbilical cord donation to successfully
transplant patients with high-risk leukemias.
Dysplastic megakaryocytes in
myelodysplastic syndrome
“Dwarf” megakaryocytes (brown)
and Gaucher cells (pink) in chronic
myeloid leukemia
“We are a very committed group,” said Dr.
Stock. “We are not satisfied with the current
therapies. We have a team of people who
will work with each patient to optimize
their treatment to get the best results.”
From Research to Practice
(Seated, from left) Dorothy Sipkins,
MD, PhD, Wendy Stock, MD, Olatoyosi
Odenike, MD, Paula Del Cerro, RN,
Peggy Green, RN, and Jane Churpek,
MD. (Standing, from left) Gordana
Raca, MD, PhD, Carol White, APN,
Todd Zimmerman, MD, Katherine
Breitenbach, RN, Nitin Jain, PhD,
Hongtao Liu, MD, PhD, Thomas
Wickert, Michael Daunov, Andrew
Artz, MD, Jean Ridgeway, APN,
Richard Larson, MD, Michelle Le Beau,
PhD, and Michael Thirman, MD. (Not
Pictured) John Anastasi, MD, John
Cunningham, MBBCh, MSc, Jerome
Dickstein, MD, PhD, Lucy Godley,
MD, PhD, Sandeep Gurbuxani, MBBS,
PhD, Elizabeth Hyjek, MD, Jennifer
McNeer, MD, Kenan Onel, MD, PhD,
James Vardiman, MD, and Howard
Weiner, CRA.
Abnormal megakaryocytes
in myelodysplastic syndrome
with isolated del(5q)
Michael J. Thirman, MD
Our researchers are involved in leukemia trials
at a national level through National Cancer
Institute-sponsored cooperative groups. Dr.
Larson has chaired the Leukemia Committee
for the Cancer and Leukemia Group B (CALGB)
for the past 15 years. The committee performs
clinical and biological studies that have led to
improved standards of care for leukemia patients.
Dr. Stock is spearheading a CALGB trial that may
improve the standard of care for young adults
with acute lymphoblastic leukemia (ALL). The
trial stemmed from insights provided by another
UChicago leukemia clinician, James Nachman,
MD, a beloved colleague and international leader
in pediatric leukemias, who passed away in June
2011. Ten years ago, Drs. Stock, Larson, and
Nachman performed a retrospective analysis that
led to the observation that young adults (ages
16-20 years) with ALL, who were treated on pediatric trials, had significantly better survival rates
than patients of the same age who were treated for
ALL in adult cooperative group trials. This finding
prompted Dr. Stock and others to develop new
clinical approaches to treat this group of patients.
“We are trying to find out if the success rate is tied
to the pediatric treatment regimen, the patients,
doctors, or the support system,” said Dr. Stock,
who explained that these young patients are
usually on their own without family members to
help them during a treatment process that takes
several years. Dr. Stock said that one way UChicago
will begin to support these patients is through a
focused, young adult oncology clinic that will be
developed in conjunction with pediatric colleagues
at Comer Children’s Hospital, including Jennifer
McNeer, MD, and John Cunningham, MBBCh, MSc.
20
UChicago currently has about 40 open adult
and pediatric leukemia clinical trials. These
and other clinical trials have formed the basis
for many scientific breakthroughs and continue
to enhance our ability to diagnose and treat
the disease. A sample of leukemia and transplant research by UChicago faculty published
during fiscal year 2010-2011 includes:
Arsenic Trioxide Improves Event-Free and
Overall Survival for Adults with APL
Including arsenic trioxide in consolidation therapy
(therapy given after a cancer has disappeared
following initial treatment) is safe and improves
event-free, disease-free, and overall survival for
adults with newly diagnosed acute promyelocytic
leukemia (APL). The findings, by Drs. Larson,
Stock, and other members of five North American
cooperative groups including CALGB, were
derived from a 3-year study involving 481 patients.
(Powell et al., Blood 116:3751-3757, 2010)
Real-time Pharmacokinetics Helps Improve
Success of Hematopoietic Cell Transplantation
Allogeneic hematopoietic cell transplants are
known to prolong life and occasionally cure
patients with advanced hematologic malignancies; however, disease recurrence remains high.
A multidisciplinary UChicago team, including
Peter O’Donnell, MD, and Koen van Besien, MD,
launched a phase I study to learn if real-time
pharmacokinetics (the study of how a drug is
absorbed, when drug action begins, how long it
is effective, etc.) could help guide more effective
administration of busulfan when this chemotherapy
drug was used as part of a transplant conditioning
strategy. The researchers found that adjusting
dosage based on real-time pharmacokinetics
resulted in improved drug efficacy and tolerability.
A phase II study is under way. (O’Donnell et al.
Leukemia & Lymphoma 51:2240–2249, 2010)
Novel TP53 Cancer Susceptibility
Mutation Uncovered
Whole-genome sequencing of a patient with no
other known cancer susceptibility genes revealed
cancer.uchicago.edu
Leukemia Stats
The American Cancer Society (ACS) predicts
that nearly 45,000 new cases of leukemia will
be diagnosed in 2011. ACS also predicts that
21,780 people will die from the disease in 2011.
New Technology Advances Individualized
Treatments for AML and Myeloid Neoplasia
Two articles in a special issue of Seminars in
Oncology, devoted to Personalized Cancer
Treatment and authored exclusively by UChicago
faculty, focused on how new technology, such as
next-generation, high-throughput DNA sequencing,
is advancing individualized therapies for leukemia.
In one paper, Drs. Godley, Le Beau, and colleagues
wrote, “The vision for the future entails an integrated and automated approach to these analyses,
bringing the possibility of formulating an individualized treatment plan within days of a patient’s initial
presentation.” The second paper, by Dr. Odenike
and colleagues described how new technology will
rapidly and more comprehensively identify gene
mutations and epigenetic alterations in individuals
Figure 3: UCMC Newly
Diagnosed Leukemia
Patients, 2006-2010
Number of newly diagnosed patients
with myeloid neoplasia. “The hope is that our
ever-expanding knowledge of the molecular
genetics of myeloid neoplasia, coupled with the
increasing availability of molecularly targeted
drugs, will allow personalized, genotype-specific
therapy to come of age in the 21st century.”
(Godley et al., Semin Oncol 38:215-224, 2011 and
Odenike et al., Semin Oncol 38:196-214, 2011)
a novel gene variant that could be a key to understanding early onset cancer. The patient had no
family history of cancer but developed breast
and ovarian cancer in her late 30s. She subsequently developed therapy-related AML (t-AML).
The patient tested negative for the BRCA1 and
BRCA2 mutations. Dr. Le Beau was among the
researchers who found a non-inherited deletion
in the TP53 gene, which encodes the p53 tumor
suppressor protein. “This case highlights the
utility of whole-genome sequencing to identify
clinically relevant germline genetic abnormalities contributing to cancer susceptibility,” they
wrote. (Link et al., JAMA 305:1568-1576, 2011)
150
100
50
At The University of Chicago Medical
2006 2007 2008 2009 2010
Center (UCMC), the number of newly diagnosed leukemia patients remained relatively
stable from 2006 to 2010. (See Figure 3)
Treatment year
In 2010, 125 total patients (74 male, 51
female) were treated for leukemia at the
UCMC. (See Figure 4) The largest number
of patients (30, 24.0%) were aged 60–69
years, followed by 29 (23.2%) aged 50–59
years, and 23 (18.4%) aged 0–29 years.
Figure 4: 2010 All
Leukemia Cancer Patients
by Gender and Age
40
35
30
Most leukemia cases (82, 65.6%) were characterized as myeloid and monocytic leukemia, followed
by 39 cases (31.2%) as lymphocytic leukemia, and
four cases (3.2%) as other leukemia. (See Table 2)
25
20
Table 2: 2010 Leukemia CASES BY Type, Gender, and Class
Total
Male
Female
Newly
Diagnosed
Recurrent/
Progressive
Disease
Myeloid & Monocytic Leukemia
82
48
34
66
16
Acute Myeloid Leukemia
59
36
23
45
14
Acute Monocytic Leukemia
3
2
1
3
0
Chronic Myeloid Leukemia
18
10
8
16
2
2
0
2
2
0
Lymphoid Leukemia
39
23
16
28
11
Acute Lymphoblastic Leukemia
20
11
9
13
7
Chronic Lymphocytic Leukemia
Other Myeloid/Monocytic Leukemia
16
9
7
12
4
Other Lymphocytic Leukemia
3
3
0
3
0
Other Leukemia
4
3
1
3
1
Other Acute Leukemia
3
2
1
2
1
Aleukemic, Subleukemic & NOS
Total Leukemia Cases
21
1
1
0
1
0
125
74
51
97
28
Number of patients
15
10
5
0
0-29 40-49 60-69 80-89
30-39 50-59 70-79
90+
Age Range
Male
Female
Personalized Therapeutics
Improve Outcomes for Leukemia
UCCCC researchers are working tirelessly to identify
genetic pathways involved in hematologic malignancies,
such as leukemia, because by understanding and
characterizing these pathways, we are able to
develop novel, molecularly targeted treatments.
Patients from the Chicago area and beyond
know that when they come to The University
of Chicago for treatment, they will receive the
unique expertise and leading-edge treatment
strategies that have made our hematologic malignancies program a program of distinction for
pediatrics, as well as for adult patient care.
Novel Treatment Approach Helps
Teen Swimmer Dive Back in Pool
Kris Egebrecht knew something was
wrong when Brandon, her teen who loves
to swim, could not get out of bed.
“I slept for 15 hours a day for 3
days straight,” Brandon said.
Kris took him to an urgent care clinic near
their home in Northwest Indiana and was
convinced a blood test would reveal a diagnosis of mononucleosis, a viral illness common
in teens. Instead, Brandon tested positive for acute myeloid leukemia (AML).
While Kris grappled with what she called
her “worst nightmare,” Brandon’s primary
care physician set the wheels in motion for
Brandon’s treatment. With an aggressive
disease like AML, time is of the essence.
treatment plan. The drug clofarabine, which is
effective in patients with relapsed AML, was
administered as the first cycle of induction therapy,
followed by four cycles of standard chemotherapy.
“The goal of this study is to achieve better
remission rates by using this more intense drug
as part of the initial therapy for newly diagnosed patients,” explained Jennifer McNeer,
MD, assistant professor of pediatrics.
Overcoming Setbacks
Brandon’s first treatment was the most challenging. He developed tumor lysis syndrome,
which occurs when chemotherapy very quickly
breaks down leukemic cells, explained Dr.
McNeer. It caused Brandon’s kidneys and
lungs to fail. Dr. McNeer said Brandon’s care
team worked together to support him until
his kidneys resumed their normal function.
Kris said she was impressed with how Brandon’s
care team explained every step of the treatment to the family, “They answered questions before I even knew I had questions.”
Brandon’s pediatric oncologist referred him to
UChicago’s Comer Children’s Hospital, where
Brandon was diagnosed with a genetic subtype of
AML that was first described at UChicago in 1983
by Michelle M. Le Beau, PhD, and colleagues.
Brandon was enrolled in an innovative clinical trial
affiliated with St. Jude Children’s Research Hospital
in Memphis, Tenn., that utilized an aggressive
(From left) Mary Paterik, RN, Brandon Egebrecht, and his mom, Kris
22
cancer.uchicago.edu
Brandon’s treatment ended earlier than initially
planned because studies have demonstrated
that four cycles of chemotherapy are as effective as five, according to Dr. McNeer. “Survival
rates in AML are certainly better than they
were years ago, but we are always working to
improve them,” she said. “It’s great we were able
to offer Brandon a unique treatment protocol.”
Brandon was diagnosed with leukemia in April
2011. By August, his treatment was completed
and he began his junior year of high school.
“I’ve grown a lot from this experience,” Brandon
said. “It has definitely changed my perspective.”
Stem Cell Donation Saves Life
of Adult AML Patient
Another success story in AML revolves around a
woman whose life was forever altered by a stranger.
In May 2007, Amelia (Amy) Vittetoe was feeling
tired and thought her thyroid medication
needed adjusting. But after extensive blood and
bone marrow studies confirmed a diagnosis of
AML, she was immediately admitted to a local
hospital near her home in Crystal Lake, Ill.
An attending physician suggested that Vittetoe
transfer to a hospital that was better equipped
to treat her disease. She considered several
Chicago area hospitals, but chose UChicago,
a decision that she said saved her life.
“That was the farthest hospital that we
could have gone to, but I know for sure
that it was the best,” she said.
Vittetoe’s multidisciplinary care team, including
Wendy Stock, MD, professor of medicine, used
molecular diagnostics to reveal that Vittetoe had
the same cytogenetic abnormality as Brandon
Egebrecht. This particular subtype of leukemia
is usually associated with a relatively good
prognosis with standard chemotherapy.
A Setback Forces a New Approach
Just 2 weeks after completing her treatments, Vittetoe’s leukemia relapsed and a
stem cell transplant was recommended.
“Even with specific subsets of leukemia, there’s
a lot of heterogeneity,” Dr. Stock said. “We still
have a lot to learn about why some cases like
Amy’s relapse and require a transplant whereas
others are cured with standard chemotherapy.”
None of Vittetoe’s relatives was a match,
but she found a perfect match through
the national bone marrow registry.
After undergoing more chemotherapy to
control her disease, Vittetoe was admitted for
her stem cell transplant where she received
intensive chemotherapy followed by the intravenous infusion of stem cells from an unrelated
donor––a 41-year-old man from Germany.
Three years later, Vittetoe is still in remission and has new priorities. She now works
as a school nurse and spends as much time as
possible with her children. She has also become
active in the national marrow donor program.
“I can’t donate stem cells or bone marrow to
anyone anymore because of my condition, but I
can help someone else find a match,” she said.
Dr. Stock said cancer researchers are currently
looking closer at these leukemias to see whether
certain new targeted therapies, in addition to
chemotherapy, will improve their outcome.
“We take each case individually and tailor the
therapy as best we can using the most sophisticated
diagnostic and therapeutic strategies available,” Dr.
Stock said. “If specific chemotherapeutic options
don’t work, then immune therapies like transplants
can work, and Amy is a perfect example of that.”
Vittetoe’s treatment kept her in and out of
the hospital and required frequent visits to
the outpatient clinic for blood transfusions.
She also participated in a national clinical trial
and received additional chemotherapy.
“It was, for sure, the most difficult time
of my life,” Vittetoe said. “The hardest
part was being away from my kids.”
23
Jennifer McNeer, MD
Amy Vittetoe and her family
Wendy Stock, MD
Cancer Research Foundation
Commitment to Cancer Research Remains Steadfast
We’d like to extend our sincerest thanks to everyone who has donated their time, talent, and treasure to The University of Chicago Cancer Research Foundation this past year. You have once
again demonstrated your unwavering commitment to raising money for cancer research.
Because of your support over the years, we have been able to develop new tools and technologies that are helping us understand more about the complexities of cancer. We have made progress
in areas, such as molecular diagnostics, proteomics, and epigenetics, and in creating individualized therapies for many types of cancer. With your continued support, our researchers will make
new discoveries that will help advance cancer prevention, diagnosis, treatment, and survivorship.
Mary Ellen Connellan
Executive Director
Cancer Research
Foundation
Ruth Ann Gillis
McGuinnis
President, Board of Trustees
Cancer Research
Foundation
Foundation Again Raises Over
$2 Million for Cancer Research
For the 6th consecutive year, The University of Chicago Cancer Research
Foundation (UCCRF) has raised more than $2 million for cancer research.
Thanks to dedicated staff, very active volunteers,
and generous donors, the $2.2 million raised in
fiscal year 2010-2011 will be used to fund 30 major
basic and clinical research projects that align with
the UCCCC’s strategic plan focus areas—cancer
risk assessment and prevention, individualized
therapies, and cancer survivorship and economics.
The following are among the UCCCC researchers
receiving Foundation grants this fiscal year:
++ Samuel Volchenboum, MD, PhD, MS,
who is performing novel work studying
24
protein production and interaction
(proteomics) in neuroblastoma, a cancer
that develops in immature nerve cells and
affects mainly infants and children.
++ Ya-Chen Tina Shih, PhD, who will direct
a new Initiative in Cancer Economics and
whose research examines the diffusion of
new and existing medical technologies in
cancer, cancer disparities, and the associated
health and economic consequences.
++ Donald Vander Griend, PhD, who discovered
that prostate cancer stem cells express a
cancer.uchicago.edu
number of genes that are normally expressed
only in embryonic stem cells. If further research
shows that these genes promote malignancy
or hormone-resistant therapy, new treatments
can be developed to target gene behaviors.
About Us
The UCCRF comprises four boards—one governance board (Board of Trustees) and three fundraising boards (Women’s Board, Auxiliary Board,
and Associates Board). The three fundraising
boards host a variety of activities throughout the
year from an elegant Cancer Ball, to a “Spring
Forward” social, to a “Cocktails for a Cure” event.
Additional fundraising is accomplished through
motivated third parties, including Kuhlman’s
Krusaders, Arlington Million Ladies, and Midway
Aquatics Club. These passionate volunteers
are part of what we are now calling “Team
Cancer,” organizations and individuals helping
us support cancer research. Corporate funding,
including a grant from Exelon, helps UCCCC
community outreach programs (See Page 12).
The UCCRF became part of the Celebrated Chefs
program in fall 2010. When a participant dines
at one of the many Celebrated Chefs restaurants
in the Chicago area using an enrolled credit
card, 5% of the bill is donated to the UCCRF.
Prestigious Shubitz Prize
The 2011 Simon M. Shubitz Cancer Prize and
Lectureship was awarded to Charles L. Sawyers,
MD, from Memorial Sloan-Kettering Cancer
Center in New York City, for his research findings that have led to new, targeted treatments
for prostate cancer. After meeting with UChicago
faculty and medical students and delivering the
noontime lecture, “Overcoming Resistance to
Targeted Therapy,” Dr. Sawyers was honored
at a dinner reception at the Gleacher Center
in downtown Chicago, which was attended by
more than 100 people. During the event, Walter
Stadler, MD, and William Dale, MD, PhD, provided
updates on their research in prostate cancer.
In 2012, the Shubitz Prize will be awarded to Joe
Gray, PhD, an internationally renowned cancer and
genomics researcher who developed a test that
has transformed how treatments are selected for
breast cancer patients. He chairs the Department
of Biomedical Engineering at Oregon Health &
Science University (OHSU) and is director of the
OHSU Center for Spatial Systems Biomedicine.
(Clockwise, from left) Cancer Center Director Michelle Le Beau, PhD, presented the 2011 Shubitz Award to Charles L. Sawyers, MD; More than 750
people attended the annual Merchandise Mart DreamHome preview party to support the UCCRF; Kulhman’s Krusaders Founder John Kuhlman and
Master of Ceremonies Tim Smithe helped raise more than $55,000 at a family event in April; Annual “No Tie” Ball Gala Co-Chairs Jeff Feste and
Lindsay Essi and Donations Chair Alex Reo oversaw the Associates Board’s annual event which raised $35,000; Swim coaches Mike Cunningham
and Laura Thomas encouraged young participants of a swim-a-thon at the Midway Aquatics Club that raised $4,000 for pediatric cancer research;
More than 100 people attended a Women’s Board cocktail party at Tiffany & Company in April in honor of Paloma Picasso (right), the daughter of
one of the 20th century’s most influential artists; and United-4 A Cure presented Vani J. A. Konda, MD (center), with $15,000 for her research on
nanocompounds for the early detection of colon cancer.
25
The UCCRF is a not-for-profit organization,
founded in 1946 by retail store entrepreneur
Maurice Goldblatt, following the death
of his brother, Nathan, from cancer.
The UCCRF plays a key role in helping the UCCCC enhance cancer care, develop more
effective and safer therapies, and promote prevention and screening research.
Your donation to the Foundation:
++ Supports innovative
research to
understand
cancer’s biomedical
complexities
UCCRF Board
of Trustees
Officers
Ruth Ann Gillis McGuinnis
President
Thomas J. Duckworth
Vice President
Ms. Wende L. Fox
Secretary
Barton G. Tretheway
Treasurer
Mary Ellen Connellan
Executive Director
Members
John R. Atchison
James N. Bay Jr.
Margaret Benjamin
Mrs. Seymour A. Cohen
Richard W. Cusack
John W. Derse Jr.
Lidia Devonshire
Mrs. Leonard S.
Florsheim Jr.
Stanford J. Goldblatt
Charles P. Hammersmith Jr.
Stephanie Harrold
Mrs. Michael Klein
John A. Kuhlman Jr.
Debbie Madlener
Bruce Ovitz
Lori Ovitz
Justin Ullman
26
++ Enables the purchase
of state-of-the-art
equipment that will
enhance diagnosis
and treatment
Honorary Trustees
Seymour A. Cohen
Ronald L. Duitsman
Leonard Lavin
J. Clifford Moos
UCCRF Women’s
Board
Officers
Mrs. David W. Devonshire
President
Ms. Cynthia Reusché
Special Advisor
Mrs. Thomas C. D’Aprile
First Vice President
Mrs. David Nuelle
Second Vice President
Karen L. Manzari
Program Chair
Barbara C. Sessions
Future Planning Chair
& Nominating Chair
Jill Gosden Pollock
Marketing &
Communication
Mrs. Charles C. Harrold III
Board of Trustees Liaison
Mrs. Robert Conrad
Annual Appeal Chair
Mrs. James Brady
Mrs. Benjamin Cox
Grand Auction Co-Chairs
++ Expands cancer
control and
prevention efforts
to save lives and
diminish the harmful
effects of cancer
Mrs. John R. Atchison
Mrs. J. Michael Crouch
DreamHome Preview
Party Chairs
Mrs. William Adams IV
Mrs. Henrik Clausen
Becky Davidson
Mrs. Thomas Eric Kilcollin
Mrs. J. Mikesell Thomas
Members-at-large of the
Executive Committee
Members
Mrs. Brayton Bunn Alley
Mrs. Alexander Anagnost
Mrs. Helena Appleton
Allison Bacon
Mrs. James N. Bay
Margaret Benjamin
Mrs. Darcy Robert Bonner
Mrs. Joseph M. Brickman
Mrs. Harris C. Brumfield
Mrs. Michael Busch
Mrs. William R. Carney
Mrs. J. Rowan Carroll
Mrs. Benjamin D.
Chereskin
Mrs. Gregory Chun
Mrs. Peter Clemens
Ms. Linda Burns Coleman
Ms. Anne H. Cox
Mrs. Michael Crane
Mrs. Richard W. Cusack
Mrs. Andrew Da Miano
cancer.uchicago.edu
++ Helps train young
scientists who will
make discoveries
that benefit our
generation and
future generations
Mrs. John Derse
Mrs. W. Brinkley
Dickerson Jr.
Mrs. James F. Dugan
Linda Finkel
Suzette Flood
Ms. Susan Florence
Mrs. Fahey Flynn
Mrs. David W. Fox
Mrs. Edward Gillette
Mrs. Thomas T. Hall
Mrs. Steven S. Helms
Lesli K. Henderson
Mrs. William J. Hokin
Blaine Kinney Johnson
Mrs. Donald A. King Jr.
Mrs. Bernard J. Kompare
Ms. Josephine
Krug-Schulte
Mrs. Andrew McGaan
Robin Josephs McGarvey
Mrs. McKay McKinnon
Mrs. Edward J. Miller
Ms. Elissa Morgante
Yoko Kusama Mosher
Mrs. Stuart Oran
Ms. Jody Oshita-Bajor
Ms. M. Bliss Packer
Shelley Johnstone Paschke
Mrs. Kirby Pearson
Mrs. Heber Pierce
Wendy Chronister Rogers
Mrs. Frank C. Schell III
Mrs. James H. Schink
Mrs. Gerald D. Skoning
Mrs. David H. Song
Nancy P. Stevens
Ms. Nancy Voss
Mrs. Keith Ward
Mrs. William Wardrop
Laura Werner
Ms. Alice
Williams-Verhoeven
Sustaining Members
Dr. Geraldine Balut
Coleman
Mrs. Robert Alan Conger
Mrs. Jeffrey Diermeier
Mrs. Gustav Horschke
Mrs. Donald Horwitz
Mrs. Robert D. Kimball III
Mrs. Robert Kramer
Mrs. Donald Levinson
Mrs. Michael McGuinnis
Ms. Sandra Reese
Mrs. Harry J. Smedley Jr.
Mrs. John C. Stone
Jennifer Kamp Tretheway
Honorary Members
Mrs. Walter E. Auch
Mrs. Wendy Becker-Payton
Mrs. Robert R. Bell
Mrs. Sharon Brix
Mrs. Seymour A. Cohen
Mrs. Leonard S.
Florsheim Jr.
Mrs. Margaret Laun-Knauf
Mrs. Arthur E. MacQuilkin
Mrs. Charles W. Tallent
Mrs. Charles Walgreen III
UCCRF Auxiliary
Board
Officers
Laurie Foster
President
Ann Mohn
Treasurer
Kathy McCarthy
Secretary
Jan Gaines
Finance
Debbie Madlener
Foundation Liaison/
Membership
Peggy Tieman
Midge Wegener
Event Chairs
Jackie Bossu
Reservation Chair
Kari Roever
Ad Book
Tierney Sharif
Publicity
Nancy Gupta
Sustaining Member
Liaison
Members
Celeste Alcock
Cindy Alston
Elizabeth Brandt
Margo Calvetti Frost
Annette Hickman
Terry Kingdom
April Krydynski Julie Sullivan
Liz Tunney Williams
Sustaining Members
Leigh Beith
Susan Bondurant
Barbara Bridges
Maggie Flanagan
Margaret Jacoby
Becky Kolleng
Joan Lancaster
Betty Ann Manganaro
Linda McCann
JoAnn McKibben
Nancy Napalo
Andrea Montross
Mary Helen Panje
Jan Peterson
Cathy Pratt
Mary Helen Ray
Ginger Stambaugh
Patti Tyska
Mary Claire White
HONORARY MEMBERS
Cheri Allen
Barbara Devlin
Susan Fraley
Darlene Landsittel
Carol Lynnes
Patsy McCurdy
Barbara Schmolze
Sharon Ubben
Christine Youngberg
UCCRF Associates
Board
Officers
Justin Ullman
President
Erin Callahan
Vice President
Darcy Bonner
Treasurer
Members
Nicholette Andrews
Laurel Buchi-Fotre
Tearle Calinog
Erin Callahan
Laura Cason
Kate Cox
Camille Cozzini
Kate Crouch
Jamie Cusack
Erica Diermeier
Lindsay Essi
Jeffrey Feste
Chris Gilmore
Suzanne Griffin
Amiel Harper
Sheila Keane
Caroline Khadder
Laura Klement
Lisa Krejcik
Julie Lissner
Mike Logan
Susan Loughran
Tom McGrath
Janelle Mentz
Amanda Pierce
Alex Reo
Megan Robb
Jordan Rovito
Melissa Rutten
Mike Ryan
Taaron Silverstein
Adam Simon
Krishna Simonetti
Jason Sochol
Rob Soraparu
Scott Stelzer
Rachel Strassner
Jenna Szkatulski
Ashley Szybala
Chaidan Upp
(From left) Women’s Board President Lidia
Devonshire, UCCRF Board of Trustees
President Ruth Ann Gillis McGuinnis, Jean
Atchison, and Joan Crouch.
(From left) Ernst Lengyel, MD, PhD, Auxiliary Board “Spring Forward” Event Co-Chair Midge Wegener, Event Co-Chair Peggy Tieman, UCCCC Director
Michelle Le Beau, PhD, Tara Henderson, MD, MPH, Samuel Volchenboum, MD, PhD, MS, and Auxiliary Board President Laurie Foster Baker.
27
Women’s Board President Lidia
Devonshire and her husband David examined some of the items available in the
silent auction at the annual cancer ball.
(From left) Liz Adams and Becky Davidson
co-chaired the annual cancer ball.
2010-2011 Honor Roll of Donors
The UCCCC gratefully acknowledges those
who have generously supported cancer
research and cancer-related programs and
services at The University of Chicago.
These donations help the UCCCC explore and develop innovative ways to prevent, diagnose,
and treat cancer. The following alumni, friends, foundations, and corporations have demonstrated their
extraordinary loyalty and commitment through leadership gifts. These gifts include cash, matching gifts,
securities and property, pledges, and pledge payments received July 1, 2010–June 30, 2011.
Director’s
Leadership Circle
$1,000,000+
American Cancer
Society, Inc.
Cancer Research
Foundation
Leukemia & Lymphoma
Society
Virginia & D.K. Ludwig
Fund for Cancer
Research
William F. O’Connor
Foundation
Diamond Circle
$250,000 – $999,999
American Cancer Society
Illinois Division, Inc.
American Society of
Clinical Oncology
Anonymous
The Breast Cancer
Research Foundation
The Chicago Community
Foundation
Crohn’s & Colitis
Foundation of
America, Inc.
Thomas J. Duckworth &
Connie Duckworth
Mrs. Arthur Edelstein
The Entertainment
Industry Foundation
Dr. Ralph & Marian
Falk Medical Trust
Foglia Family Foundation/
Mr. & Mrs. Vincent
W. Foglia
Gabrielle’s Angel
Foundation for
Cancer Research
Goldman Sachs
Philanthropy Fund
28
Susan G. Komen Breast
Cancer Foundation
G. Harold & Leila Mathers
Charitable Foundation
Bernice* & Earl Meltzer
Pfizer, Inc.
Searle Funds at
The Chicago
Community Trust
Segal Family Foundation /
Carole B. &
Gordon I. Segal
The Simmons
Mesothelioma
Foundation
The UCCRF Women’s
Board
Sapphire Circle
$100,000 – $249,999
Abbott
American Society for
Radiation Oncology
(ASTRO)
Anagen Therapeutics, Inc.
Anonymous
Avon Foundation
Ben May Charitable Trust
Blum-Kovler
Foundation, Inc.
Burroughs Wellcome Fund
Cancer & Leukemia
Group B Foundation
Cancer Research Institute
Damon Runyon-Walter
Winchell Cancer Fund
Elsa U. Pardee Foundation
Enivar Charitable Fund
Fanconi Anemia
Research Fund, Inc
The Field Family
Flight Attendant Medical
Research Institute
Focused Ultrasound
Surgery Foundation
The Francis L. Lederer
Foundation
Mr. & Mrs. Richard
Gonzalez
Jeffrey B. & Penny J.
Hecktman, Hillary
Hecktman, Candace
and Daniel Arnold,
Valerie Hecktman
Hyundai Motor America
Mr. Kenneth R. Jensen
Kirkland & Ellis
Foundation
Kovler Family Foundation
Leukemia Research
Foundation, Inc.
Michael Rolfe Pancreatic
Cancer Foundation
National Marrow
Donor Program
Project Ladybug
Prostate Cancer
Foundation
St. Baldrick’s Foundation
The UCCRF Auxiliary
Board
The V Foundation for
Cancer Research
Zaccone Family
Foundation
Ruby Circle
$50,000 – $99,999
Alvin H. Baum
Family Fund
American Society for
Blood & Marrow
Transplantation
Bears Care Foundation
The Brinson Foundation
Cantor Fitzgerald
Relief Fund
Diermeier Family
Foundation / Mr. & Mrs.
Jeffrey Diermeier
cancer.uchicago.edu
The Dominick’s
Foundation
FJC A Foundation of
Philanthropic Funds
Ronald & Sondra Katz
Lung Cancer Research
Foundation
Marsha Rivkin Center
for Ovarian Cancer
MPD Foundation
Mr. Richard K. Mullin &
Ms. Mary J. Henry
Neuroblastoma Children’s
Cancer Society
The Ovarian Cancer
Research Fund, Inc.
Jeff, Linda & Katie Sluman
Mr. & Mrs. Nicholas
J. Vogelzang Jr.
Platnium Circle
$25,000 – $49,999
Anonymous
American Heart
Association
Mr. & Mrs. James N. Bay Jr.
Boston Scientific
Corporation
Mr. William Connelly
Mildred & Marv Conney
Mr. Jerome Contro
Robert & Susan Cook
Craig & Janet Duchossois
Estate of Joyce M. Perlman
Dennis* & Kathleen
Ferguson
Jim & Karen Frank
The Helen & Bernard
Kozloff Family
Foundation
Housewares Charity
Foundation
Howard Hughes
Medical Institute
J.B. Pritzker Family
Foundation
Kazan, McClain, et al
Foundation, Inc.
Denise Kozloff
Mr. E. Bernard McKay
Ms. Rita Meltzer
Merchandise Mart
Properties, Inc.
Michael Reese Health Trust
Multiple Myeloma
Research Consortium
National Foundation for
Cancer Research
Respiratory Health
Association of
Metropolitan Chicago
Mr. Anthony Santacroce
Valda & Robert Svendsen
Foundation
Ms. Marie Wilkinson*
Mrs. Harry Woldenberg
Gold Circle
$10,000 – $24,999
John Amboian, AB’83,
MBA’84 & Ann Lee
Amboian, AB’83
American Lung Association
Mr. & Mrs. Bruce Anderson
Anonymous
Arlington Million Ladies
Barclays Capital
Mr. & Mrs. Lawrence
Benjamin
Biogen, Inc.
Mr. & Mrs. James Bozik
Ms. Kathleen E. Chapski
Mr. & Mrs. Benjamin
Chereskin
Chicago West
Suburban Unico
Chicago White Sox
Charities, Inc.
Mr. & Mrs. Andrew
Da Miano
Mr. & Mrs. David W.
Devonshire
Eli Lilly & Company
Exelon Corporation
Fidelity Charitable
Gift Fund
Ms. Jean Gelbort
Mr.* & Mrs. Robert
B. Gelbort
John & Charlotte Gilmore
Grosvenor Capital
Management, L.P.
Mr. & Mrs. Charles
C. Harrold III
Harry F. & Elaine Chaddick
Christopher C. Craven
Heat & Frost Insulators
I-I District Kiwanis
International Spastic
Paralysis Research
29
The John & Charlotte
Gilmore Foundation
John Hayes Memorial
Golf Outing
John W. Anderson
Foundation
Johnson & Johnson
Pharmaceutical R&D
Junior Cancer League
Kadrovach-Duckworth
Family Foundation
The Kathleen B. &
Charles R. Walgreen III
Charles R. Walgreen III
Katten Muchin & Zavis
Foundation, Inc.
K-Five Construction
Corporation
Klein Tools, Inc.
Ms. Josephine M. Krug &
Mr. Gerard Schulte
Mr. William J. Krug & Ms.
Marta Ramirez Krug
Andrea & Benjamin
Leshem
Mr. & Mrs. Michael
J. McGuinnis
Mr. William J. Meyer
John Nuveen & Co.
Incorporated
Mr. & Mrs. John Paleczny
Partnership for Cures
Mrs. Cynthia M. Reusché
Mr. Harvey Schaffer
Mr. Charles G. Schultz
UBS AG
The UCCRF Associates
Board
The Windy City Classic
Foundation
Mr. & Mrs. Justin Ullman
Wells Fargo Foundation
Silver Circle
$5,000 – $9,999
Mr. Grant Achatz
Mr. & Mrs. William
Adams IV
Anonymous (2x)
Mr. & Mrs. Patrick J. Baert
Mr. & Mrs. Joel Barnett
Mr. Neil Berg
Berger Company
Ms. Cynthia M. Bernardi
Mr. Larry Berning
Mr. & Mrs. Thomas Brady
Brian Delanty Invitational
Mr. Zachary B. Bulwa
Charles Hammersmith &
Carol Hammersmith
Family Foundation / Mr.
Charles P. Hammersmith
Chubb Corporation
Cooney & Conway
Tricia & Benjamin Cox
Mr. & Mrs. J. Michael
Crouch
Cure It On The Court
Ms. Carol K. Dugan
The Duk Young
Foundation / Mr. &
Mrs. Gregory H. Chun
Mr. & Mrs. Michael
Hannafan
Mr. Austin L. Hirsch & Ms.
Beth Gomberg-Hirsch
Ms. Deanna Hodges
Mr. Marvin Jacobs
JBS Foundation
The Lisa Klitzky
Foundation
Rally for Kids
Marlowe & David Klitzky
Mr. Robert A. Lopp
Modestus Bauer
Foundation
Moneris Solutions, Inc.
Mr. J. Clifford Moos
Mr. Stephen D. Nechtow
Paul & Joan Rubschlager
Foundation / Paul &
Joan Rubschlager
Jill Pollock & Gordon
Lee Pollock, MBA’73
Mrs. Linda Quasney
Mr. Gregory P. Richards
Searle Family Trust
Douglas* & Loretta Spesia
Mr. & Mrs. Robert Swartz
Tieri Family Fund
Vanguard Charitable
Endowment Program
Verdura / E. J.
Landrigan, Inc.
William Blair & Company
Dr. James Williams
Bronze Circle
$2,500 – $4,999
American Society of
Hematology
Mrs. Alexander Anagnost
Anonymous (2x)
Mr. & Mrs. John R.
Atchinson
Mr. Peter Bajor & Ms.
Jody Oshita-Bajor
Sarah & Blake Berg
Ms. Camilla Dietz Bergeron
Bolton Sullivan Fund
Marta Bonner & Darcy
Robert Bonner
Mr. & Mrs. Harris
Brumfield
Mr. & Mrs. John T. Callahan
Carleton College
Henrik & Annemette
Clausen
Ms. Rebecca Davidson
Deutsche Bank
Securities, Inc.
Dr. Steven Doran
Drs. Doran, Capodice,
Efaw & Ocheltree
Mr. & Mrs. Louis A. Ebert
Estate of Lillian Z.
Bronkhurst
Mr. Marc Feliciano & Mrs.
Carolyn Pleyto-Feliciano
Paul Fricke, MBA’72
Dr. & Mrs. Damien A. Gabis
Mr. & Mrs. Steven S. Helms
Frances Henkel &
Michael Henkel
J.S. Frank Foundation
Mr. & Mrs. Jan Jamison
Mr. Ron Johnson Sr.
Mr. & Mrs. Thomas
E. Kilcollin
Lance Armstrong
Foundation
Mrs. Elisabeth F. Lanzl
Judy & Wayne Lewis
Mr. Laurence Lewis
Lilly
Mr. & Mrs. Robert Linn
Mr. Zdenck Machalka
Maurice H. Givens
Charitable Trust
Mr. Peter A. McLean
Jill & Paul Meister
Mrs. Edward J. Miller
Ms. Tamara L. Mortell
Oppenheimer & Co.
Mr. & Mrs. Timothy Ozark
Mr. & Mrs. Marvin
C. Peterson
Mr. & Mrs. Stephen Quazzo
Robert Okin
Foundation, Inc.
Mr. James L. Rosenbloom
RST Memorial Cancer
Foundation
Mr. & Mrs. David
R. Schwartz
Select Equity Group, Inc.
Coleman R. Seskind, MD
Mr. John Silverman
The Stephen Family
Mr. & Mrs. Barton
G. Tretheway
US Trust/B. Of A. Private
Wealth Mgmt.
Mr. James M.
Weichselbaum & Ms.
Susan L. Weichselbaum
Dr. David H. Whitney &
Dr. Juliana Chyu
Mr. & Mrs. Samuel Zell
Donations
Support:
Novel
proteomics
study of
neuroblastoma,
a disease that
affects mostly
infants and
children.
Founders
$1,000 – $2,499
Mr. & Mrs. Brayton B. Alley
Mr. & Mrs. Richard
Almeida
Ms. Joanne Brooks Alter
* Deceased
Donations
Support:
Sophisticated
analysis of highthroughput
DNA
sequencing
results to help
develop more
individualized
cancer
therapies.
Amanda Dombrowski
Scholarship Fund
AmeriTrade, Inc.
Amgen, Inc.
Mr. & Mrs. Robert
O. Anderson
Mr. Jeffrey P. Aranyos
Ms. Joan Aranyos
ArcelorMittal
Arch W. Shaw Foundation
Ms. Diane Patricia Atwood
& Mr. Paul J. Reilly Jr.
Mr. & Mrs. George Babson
Dr. Richard L. Baron
Mr. Timothy A. Barrows
Ms. Nancy Bellew
Renee Belman
Ms. Bonnie J. Benson
Mr. Steve Berger & Ms.
Shereen Taylor-Berger
Ellen H. Block
Mr. James F. Brady
& Mrs. Terese
Eckelkamp-Brady
Mr. & Mrs. Russell
Brandstetter
Mr. Steven L. Braun
Brooks Family Trust
Ms. Ruth E. Bruch
Mr. & Mrs. Samuel
Buchsbaum
Pauline M. Burelli
Melissa & John Burnstine
Mr. & Mrs. Michael
J. Busch
Mr. & Mrs. William F. Cahill
Carleton Cuts for Cancer
Annette Carroll, MBA’85
& John Rowan
Carroll, MBA’96
Mr. & Mrs. John F. Chizmar
Mr. & Mrs. Peter Clemens
Mr. & Mrs. Neil Coleman
The Comer Family
Foundation
Mr. & Mrs. Kevin
A. Connellan
Mr. & Mrs. Robert
L. Conrad
Patricia O. Cox
Ms. Helen B. Daigle
Thomas C. D’Aprile &
Nichole D. D’Aprile
Mr. William G. Dempsey
Marti DeGraaf &
Toby Mack
Mr. & Mrs. John
W. Derse Jr.
Mr. Richard Dombrowski
Mr. & Mrs. Ronald
L. Duitsman
Ellen & Ronald Block
Family Foundation
Dr. Joseph Favia
Mr. & Mrs. Fred Feinstein
Mr. & Mrs. Paul J. Finnegan
30
Dr. & Mrs. Timothy Flood
Mr. & Mrs. David W. Fox Jr.
Dr. Gregory Friberg
Mr. Thomas L. Fritzlen Jr.
Mr. Peter Gaido
Garrett Family Foundation
Mr. & Mrs. Scott Garrett
Mr. & Mrs. James Gelbort
GEM Realty Capital, LLC
Mr. & Mrs. Edward
S. Gillette
Mr. & Mrs. Thomas
Glettsman
The Greater Kansas City
Community Foundation
Dr. & Mrs. Raj P. Gupta
Mr. David P. Hartney
Winifred & Kirt Hayes
HEB Foundation
Ms. Katie Hicks
Mr. & Mrs. Laurence
Dean Hill
Mr. & Mrs. Howard
Hoffmann
Mr. & Mrs. Timothy Hurd
Illinois Prairie Community
Foundation
Mr. Kenneth M. Jacobson
James R. & Lesley
B. Anixter Family
Foundation / Mr. &
Mrs. James Anixter
Jamison, Inc.
Mr. Steven D. Jensen
Jewish Federation of
John & Jacolyn
Bucksbaum Family
Foundation / John &
Jackie Bucksbaum
Mr. & Mrs. Rob Johnson
Mr. & Mrs. Roger
B. Johnston
Jordan Industries
Incorporated
Ms. Carol W. Keenan
Mrs. Gwen Klein
Paul Knapp, MBA’77
& Nancy Knapp
Mr. Neal Kottke
Mr. John A. Kuhlman Jr.
Mr. & Mrs. Gilbert W.
Kurschner Jr.
Julius Lewis
Mr. John P. Lynch
Mr. & Mrs. Craig W. Mann
Mr. & Mrs. George Mann
Karen Manzari &
Tony Manzari
Mr. & Mrs. James F. Martin
Ms. Nina B. Matis
Ms. Noreen McGuire
Dr. & Mrs. McKay
McKinnon
Merrill Lynch & Co.
Foundation, Inc.
Mr. & Mrs. Stephen Meskan
Mr. & Mrs. Robert
Johns Mignin
Mr. & Mrs. Brian P. Miller
John P. & Carol E. Mordach
Morgante Wilson
Architects, LTD. / Mr.
Fred Wilson & Ms.
Elissa Morgante
Mr. & Mrs. Robert
S. Morrison
Evelyn Mueller
Ms. Harriet Nathan
Neal, Murdock &
Leroy, LLC
Mr. Langdon D. Neal &
Ms. Jeanette Sublett
Mr. Nick Niciforo
Northwestern Mutual
Foundation
Mr. & Mrs. David Nuelle
Bruce & Lori Ovitz
Packard Research
Foundation
Ms. Mary Bliss Packer
Kathleen Palla
Mr. Nicholas D.
Pannacciulli
Mr. & Mrs. Brett Paschke
Debra & Robert Peterson
Mr. & Mrs. Heber Pierce
Colette O. Pollock
Kenneth Samuel
Polonsky, MD & Ms.
Lydia Ray Polonsky
PolyScience
Mr. Thomas H. Quinn
Rally For Kids With
Cancer Foundation
Mr. & Mrs. Lucius E. Reese
The Rhoades Foundation
Mr. & Mrs. David Richter
Mr. & Mrs. Michael
Gerard Rippey
Mr. & Mrs. Randall
S. Rogers
Mr. John C. Rosengren
Mrs. Elinor Salvino
Mr. Scott Sauer
Ms. Nicole C. Schachner
Mr. & Mrs. Frank
Charles Schell III
Mr. & Mrs. Richard
J. Schiene
Mr. & Mrs. James Schink
Ms. Martha E. Schmidt
Mr.* & Mrs. Richard Scully
Mr. & Mrs. Rob Selati
Mr. & Mrs. Rex Sessions
Mr. Arch Shaw II
Ilene Warshawsky
Shaw, AM’75
Ms. Jean E. Sheridan
Mr. & Mrs. Frank M. Sims
Mr. & Mrs. Gerald
D. Skoning
cancer.uchicago.edu
Donna Speigel
Ms. Geraldine Stein
Ms. Bonnie J. Struthers
Mr. & Mrs. Timothy
P. Sullivan
Supera Family Foundation
Mr. & Mrs. John Svoboda
Mr. & Mrs. Mikesell
Thomas
Ms. Mary L. Tieri
Dr. Everett E. & Dr.
Tamara Vokes
Ms. Nancy Voss
Mr. & Mrs. Franklin
Wallace
Mr. & Mrs. Keith Ward
Mr. & Mrs. William
S. Wardrop Jr.
Mr. James Watson Jr.
Mr. Roy Weaver
Mr. & Mrs. Michael Werner
Ms. Lynn M. Wesley
Ms. Alice WilliamsVerhoeven & Mr.
Gary Verhoeven
Winston & Strawn
Ann S. Wolff
Mr. Dominic Zaccone
Dr. & Mrs. Lawrence
Zachary
Benefactors
Under $1,000
A. Smaltz Inc./DBA
The Ground Crew
Mr. Joel Aarons
Darrow Abrahams
Ms. Ellie Abrams
Ms. Lucille Ackerman
Ms. Lucille N. Ackerman
Mr. Hall Adams III
Barbara Stolberg Adelman,
AB’70, MBA’76 &
Steven Adelman
Ms. Donna Adelsperger
Ms. Yolanda Torrisi Adler
Agape Foundation
Ms. Naza Agassi
Mr. Peter Akemann
Ms. Kate Alcantara
Mr. & Mrs. Dino Alex
Mr. Constantine Alexander
Ms. Nell Alexander
Ms. Shirley C. Alexander
Allard Rental Corporation
Mr. & Mrs. Chad M. Allen
Ms. Marianne E. Allen
Mr. & Mrs. Gary A. Allen
Mr. Ronald J. Allen
Mr. & Mrs. Stephen E. Allen
Mr. Leo F. Alt
Alternative Reproductive
Resources
Ms. Martha Altmin
Ms. Hope Alvarado
Mr. John Amato
Amgen Foundation Inc.
Mr. William Amonda
Mrs. Helen Andersen
Ms. Dawn M. Anderson
Ms. Georgean L. Anderson
Mrs. Helen R. Anderson
Ms. Janice Anderson
Mr. Douglas Andrews
Ms. Nicholette Andrews
Mr. George Andronikidis
Mr. & Mrs. Pete Angelos
Mr. Michael Anguiano
Anonymous (3x)
Mr. John R. Appleton
Dr. Maureen K.
Archambault
Ms. Darlene L. Ardelean
Mr. William Argall
Dr. Eva S. Arkin
Mr. & Mrs. Edward
G. Arman
Ms. Joy Arnold
Mr. & Mrs. Bruce Arquilla
Mr. James Austin
Mr. & Mrs. Myron D. Austin
Auto Parts City, Inc.
Azemi’s Management, LLC
Ms. Lesli Babbs
Mr. Robert F. Bacigalupo
J. Douglas Bacon &
Allison Bacon
Mr. John Badeusz
Mr. & Mrs. Thomas E. Baier
Dr. & Mrs. Kent N. Bailey
Bailey-Love Mortuary
Baker Tilly Virchow
Krause, LLP
Mr. Bradley Bakle
Ms. Mary N. Baldwin
Ball State University
Ball State University –
Department of
Journalism
Ball State University –
Dean, Teachers College
Mr. Marshall J. Ball*
& Mrs. Paula Ball
Mr. & Mrs. Eugene
F. Bandy
Bank of America
Foundation
Barack Ferrazzano
Kirschbaum & Nagelberg
Mr. & Mrs. Christopher
Barber
Mrs. Jane Barbera
Ms. Megan Barcheski
Barker & Castro LLC
Mr. Lee Charles Barker
Ms. Elizabeth M. Barnett
Mr. John R. Barney
Ms. Nancy Barrett
31
Ms. Sheila Marguerite
Barrett
Barry C. Kessler &
Associates
Ms. Robbie Barscz
Ms. Vida Bartkus-Murray
Mr. & Mrs. David V. Basile
Mr. & Mrs. Shale D. Baskin
Robert Batlivala
Ms. Mary F. Baudino
Ms. Marcia Baugh
Mr. & Mrs. Bernard
M. Baum
Mr. & Mrs. Richard
W. Baum
Mr. Oscar E. Rebollo &
Ms. Suzanne Baum
Ms. Vittoria Baum
Mr. Christopher J.
Baumbach
Ms. Margaret Baumgartner
Baxter Employees
Giving Campaign
Baxter International
Foundation
Bear Cartage &
Intermodal, Inc.
Mr. William Bebonis
Ms. Maryellen Begley
Ms. Michelle Beierle
Mr. J. Edward Bell
Ms. Nicole Bell
Mr. Ricky J. Bender
Mr. Richard M. Bendix
Ms. Joanne J. Benedick
William J. Bennett III, DDS
Ms. Jeanne B. Bercovitz
Mr. & Mrs. James
P. Bereolos
Mr.* & Mrs. Louis A. Berger
Mr. Blake M. Berish
Mr. & Mrs. Alan G.
Berkshire
Mrs. Linda Berkson
Mr. & Mrs. Arthur
L. Berman
Mr. Arthur M. Berman
Mr. & Mrs. Mark Bernstein
Mr. Scott A. Berry
Mr. & Mrs. Phillip L. Best
Ms. Constance Beucus
Ms. Judith A. Beyer
Marjorie Biederman
Mrs. Andrea Biel-Cohen
Friends of the Biological
Sciences
Ms. Joanne Linda Biondi
Mr. Lewis Bird
Bishop Plumbing, Inc.
Ms. Sharon M. Bishop
Mr. & Mrs. C. Edward
Bjorncrantz
Mrs. Raye Black
Ms. Tambra Black
Ms. Gail Blackmun
Mr. Gilbert Blackmun*
Ms. Julie Blackmun
Mr. Ronald Blaine
Ms. Ruth Blatt
Lexis S. Blitstein
Mr. Neil Blitstein
Ms. Mary Lou Block
Ms. Francine Bloom
Board of Education
District 27
Mr. Matthew C. Boba
Chris & Natalie Boden
Michele L. Bograd, PhD
Mr. & Mrs. Gary R. Bohl
Mr. Julius Bokodi
Ms. Leah Bolger
Mrs. Lillian F. Bolkovatz
Mr. & Mrs. David Bolson
Mr. & Mrs. Scott Bondurant
Mr. Gary Bonk
Mr. Stephen Bonnema
Mr. & Mrs. Dennis S.
Bookshester
Mr. & Mrs. Daniel J. Boote
Ms. Eva Bordeaux
Mr. & Mrs. Ronald
J. Borden
Ms. Suzanne Boren
Mr. & Mrs. Erwin
R. Borowsky
Gerard A. Boston, DVM
Ms. Joyce E. Both
Ms. Laurice Boulos
Ms. Lynne E. Bouzeos
Ms. Susan A. Bovbjerg
Mr. Ed Bovich
Mr. Jeremiah Bowman
Mr. Terry A. Bowman
Mr. & Mrs. John T. Boyle
Mr. Bruce C. Boynick & Ms.
Andrea A. Moonsammy
Mr. John A. Bracha
Ms. Adelaide B. Brady
Mr. Brooke Brady
Mr. & Mrs. Curtis Brandon
Mr. Hubert Brandt
Mr. & Mrs. John A. Brandt
Mr. & Mrs. John Brane
Ms. Maryellen B. Brault
Ms. Flora Braziel
Ms. Kathryn G. Brenner
Mr. Jason Brezler
Mr. & Mrs. Joseph
M. Brickman
Mr. & Mrs. Thomas
A. Briden
Ms. Deborah Briehan
Mr. Richard A. Broeren
Brotherhood of Asea,Inc.
Mr. & Mrs. Raymond
Brower
Ms. Jennifer Brower
Mr. Charles M. Brown
Ms. Fern G. Brown
Mr. & Mrs. Frederick
J. Brown
Ms. Jennifer Brown
Mr. & Mrs. Michael
J. Brown
Ms. Rebecca A. Bruckner
David Brueggen, MBA’75
Mr. Daniel P. Bruggeman
Mr. & Mrs. Jack F. Bryant
Mr. & Mrs. John C. Bucher
Mr. & Mrs. John
A. Buck, III
Ms. Marguerite R.
Buckingham
Mr. Paul A. Buckley
Ms. Laura Budd
Ms. Paula R. Buddy
Mrs. Alice B. Burgess
Mr. & Mrs. Craig Burgess
Mr. & Mrs. Gregg Burgess
Ms. Vicki L. Burgess
Raphael A. Burnstein, PhD
Mr. & Mrs. James Bushnell
Ms. Heather Bushong
Mr. Bryan Bussan
Mr. & Mrs. William
J. Butrym
Mr. J. Denson Buttrey
Mr. Steven Buzzard
Mr. Bryan Bylica
Mr. David D. Byrne
Mr. & Mrs. Patrick T. Byrne
Ms. Carol J. Byrnes
Ms. Lynn Byrnes
Ms. Barbara A. Byron
Mr. David S. Byron
Ms. Angelinn M. Caffarini
Mr. Michael J. Calandro
Mr. & Mrs. G.J. Caldwell
Mr. & Mrs. Martin
T. Callaghan
Ms. Deborah Callahan
Ms. Erin Callahan
Callaway Golf Company
Foundation
Ms. Corina M. Cardamone
Mr. & Mrs. John A. Carlson
Carnegie-Mellon University
Ms. Emanuela Z. Carney &
Mr. William R. Carney
Ms. Mary A. Carney
Carolyn AlbertKincl Design
Mr. Philip Carrier
Mr. & Mrs. Duane Cart
Ms. Susan Joanne Carton
Mr. & Mrs. Douglas Carucci
Mr. & Mrs. Timothy
J. Cavanagh
Celebrated Chefs
Mr. & Mrs. Denis Cerezo
Ms. Jeannene Chadruc
Donations
Support:
Reconstructive
microsurgery for
the treatment of
breast cancer.
* Deceased
Donations
Support:
Immunotherapy
for the
treatment of
melanoma, one
of the deadliest
cancers.
Ms. Z. Kathy
Chamah-Cameron
Chaney-Monge School
District #88
Chaney-Monge Teacher’s
Organization
Ms. Betty Charles
Ms. Ching-Fen Chen
Chicagoland & Italian
American Charitable
Organization
Ms. Laura M. Chihara
Ms. Linda C. Chizmar
Ms. Rose Chodzinski
Mr. & Mrs. Burton Chotiner
Ms. Sandy Christafferson
Mrs. Wendy Chronister
Mr. & Mrs. Donald
Chudacoff
City Publication North
Shore Chicago
Ms. Nancy J. Claar
Mr. & Mrs. Peter Claeys
Ms. Marjorie
Bomberger Clark
Mr. Stevie Clark
Mr. & Mrs. Charles
F. Clarke III
Classic Touch Painting, Inc.
Mr. & Mrs. Kenneth
L. Clement
Ms. Laura Clements
Ms. Toni Clementz
Ms. Emilie Cloutman
Mr. & Mrs. Thomas
R. Cloutman
Mr. Zack Cloutman
CM&P Consultants, LLC
Ms. Lauren Coburn
Mr. Jeff Coburn & Ms.
Pamela Hanratty
Mr. & Mrs. Richard
L. Cohan
Mrs. Barbara P. Cohen
Dr. Ezra Cohen
Ms. Jill Cohen
Ms. Rosanne Cohen
Mr. Stuart Cohen
Mr. & Mrs. Barry Cohn
Mrs. Elaine Stone Colburn
Dr. Geraldine Balut
Coleman
College of St. Benedict
Mr. & Mrs. Michael
F. Collins
Mr. & Mrs. Ronald
A. Colosimo
Mr. Byron B. Colvis
Community Shares
of Minnesota
Ms. Carrie Compobasso
Ms. Heather Concklin
Richard S. Conen, DDS &
Mrs. Beth Miller Conen
Connors Industrials, Inc.
32
Mr. Robert E. Connors
Ms. Merle R. Cooper
Mr. & Mrs. Arthur Coren
Alene Corken
Mr. & Mrs. Dean
P. Coronato
Ms. Cara Cosentino
Country Curtains
Mail Order Inc.
County Municipal
Employees Supervisors
& Foremens Union 1001
Mr. Matthew Cowen
Ms. Karen A. Cowperthaite
Ms. Catherine Cox
Ms. Josephine A. Cox
Mr. & Mrs. David J. Cox
Ms. Rebecca Cox
Mr. Fred Crandall
Mr. & Mrs. Michael
E. Crane
Mr. Bruce Cravens
Mr. Matthew Cross
Keith Crow, JD’86 &
Elizabeth Parker, AM’87
Mr. & Mrs. Merwin R. Crow
Mrs. T. M. Crowley
Ms. Carol J. Culberson
& Mr. James Fehling
Jaime Cumberworth-Sisti
Ms. Dorothy L. Cummens
Ms. Alexandra Rose
Cunliffe
Ms. Kathleen Curran
Barbara Flynn Currie,
LAB’58, AB’68, AM’73
Mr. James Cusack
Mr. & Mrs. John A. Cutler
Mr. Robert Cutler
Mr. & Mrs. Le Roy
T. Czarnecki
Ms. Doris Czarobski
Ms. Denise Czuprynski
Ms. Katherine Dagres
Mr. & Mrs. Eric Dahl
Mr. & Mrs. Robert
Daldegan
Dare To Share
Ms. Rachel Silverman
Darlow
Mr. & Mrs. Alex Daudsyah
David Apple Ltd.
Mr. & Mrs. Ellsworth
G. Davis
Mrs. Laura Sims Davis
Mr. & Mrs. Harry W. Davis
Ms. Elizabeth Day
Mr. Hybo L. De Blecourt
Ms. Jillayne E. Deakins
Mr. Santolo M. Deblasio
Mr. Steven Deer
Mr. Dean D. Degan
Ms. Joan E. Dehnert
Mr. Ardell Deiber
Mr. & Mrs. Philip Deiotte
Mr. Akinwande Delano
Ms. Angela L. Delgado
Mr. & Mrs. Steven Deli
Denemark Periodontal
Specialists, LTD
Mr. & Mrs. Paul Denemark
Ms. Denise Dentley
Mr. Grant DePorter
Mr. & Mrs. Tony DeSalvo
Design Window
Solutions, Inc.
Ms. Rita Dessner
Mr. Ronald DeTella
John R. DeVries, DVM
Mr. & Mrs. Anthony
M. Di Lorenzo
Mr. Gerald Diamond
Mr. Carlos Dias
Dick Van Dyke
Financial, LTD.
Ms. Lillian L. Dick
Mr. Raymond Dickinson
Dickson & Hasenbalg
Mr. Jeffrey J. Diehl
Mr. Robert F. Dieli
Mr. Vassilios Dimitriadis
Discover Financial
Services
Ms. Elizabeth Diver
Mr. & Mrs. Dan Dixon
Mr. Peter Dixon
Mr. & Mrs. David Dobbs
Mr. William Robert
Dodds Jr.
Ms. Karyn Louise Doerfler
Mr. Duane A. Doerle
Mr. John A. Doerrer
Ms. Marie E. Doleman
Ms. Marlene Domash
Ms. Priscilla W. Dombek
Ms. Grace M. Donaghey
Mr. Phillip B. Donenberg
Ms. Joy Ann Donewald
Ms. Kathleen Donohue
Mrs. Virginia K. Donohue
Mrs. Nancy S. Donovan
Dr. Amir Dorafshar
Mr. Michael Doran
Dr. & Mrs. Heratch
O. Doumanian
Dowd Wescott Group, LLC
Ms. Mary Vita Drennan
Mr. & Mrs. Angelos Dres
Mr. & Mrs. Ross Drobny
Mr. & Mrs. Michael Dry
Ms. Margaret R.
Du Bernard
Ms. Loretta Dubovik
Ms. Helene Dubow
Mr. & Mrs. William
J. Ducey
Ms. Claire Ducey-Bach
cancer.uchicago.edu
Mr. George E. Duchossois
Mr. & Mrs. Richard F. Duffy
Nancy Dugan, MBA’97
& James Dugan
The Duncan Family
Mr. & Mrs.* E.R. Dunn
Mr. & Mrs. Ray A. Dybala
Mr. & Mrs. Gerald T. Eager
East-West Home Title, Inc.
Mr. Daniel A. Edelman
Ms. Julia Edelmann
Mr. Ryan Edlefsen
Ms. Judith Edwards
Ms. Carolyn C. Eggers
Ms. Lynn Eikenbary
Mr. & Mrs. Patrick Eilers
Ms. Mary A. Ekovich
Mrs. Victoria Eley
Mr. Dale J. Elkins
Mr. Michael J. Elkins
Dr. Leonard D. Elkun
Mr. & Mrs. Peter Elliott
Mrs. Margaret S. Elliott
Ms. A.J. Ellis
Ms. Laurie J. Elm
Ms. Gloria D. Elmore
Ms. Phyllis Elsbury
Mr. John W. Empfield &
Mrs. Mary Donohue
Empfield
Mr. & Mrs. Donald
L. English
Mr. & Mrs. Scott
M. Engstrom
Mr. & Mrs. Thomas
J. Enrici
Mr. John J. Enright
Ms. Charlene Entman
Mr. & Mrs. Jerry W. Epton
Mr. & Mrs. Daniel
K. Ericson
Mr. & Mrs. Sam D. Esposito
Mr. & Mrs. Mark Essi
Ms. Lindsay Essi
Mr. Allan Etzbach
Ms. Elizabeth Eugenio
Ms. Katherine K. Evans
Mrs. Louise M. Evans
Ms. Margaret M. Evans
Mr. & Mrs. Ronald L. Evans
Mr. Reese L. Evans
Mr. & Mrs. Shane Exner
Mr. & Mrs. Bryan A. Fabry
Facing the Mirror with
Cancer, LLC
Faermark & Williams LLC
Ms. Mary Jo Fasan
Mrs. Evelyn K. Faulstich
Ms. Gayle L. Fazzini
Mr. Scott B. Feder
The Federal Metal
Company
Mr. & Mrs. Mitchell
Feldman
Mrs. Terri R. Feldman
Mrs. Alice E. Felton
Mr. & Mrs. John A.
Ferguson
Mr. Daniel Ferri
Mr. Jeffrey Feste
Krage Feste
Ms. Carole L. Fiducci
Barbara Field &
Lawrence Field
Mr. & Mrs. Theophilos
G. Fifles
Mr. & Mrs. Robert Finkel
Ms. Elaine Finnegan
Mrs. Lauren Fischer
Mrs. Cheryl Fisher
Mr. & Mrs. Don Fisher Jr.
Ms. Mary Fisher
Mr. Russell Fishman
Dr. & Mrs. Frank W. Fitch
Ms. Jan Fitzgerald
Mr. Stephen W. Fitzpatrick
Mr. & Mrs. Richard
S. Fleisher
Ms. Kathie Florsheim
Jill Folan
Ms. Maureen Foran-Mocete
Ms. Margaret Fosmoe
Mr. L. James Lawson III
& Mrs. Wende L. Fox
Dr. & Mrs. Harry
A. Fozzard
Ms. Sonia Franco
Mieczyslawa Franczyk
Ms. Christine C. Franklin
Mr. & Mrs. Philip
G. Franklin
Mr. & Mrs. Jay Franks
Frederick & Greta
Smiley Charitable
Foundation Inc.
Mr. Grum N. Frederick
Ms. Lynn Fredrickson
Ms. Paula Fredrickson
Ms. Margaret Fredson
Ms. Judy A. Freeze
Mr. Louis E. Freidheim Jr.
Dr. & Mrs. Robert
Alan Freilich
Mr. Frank French
Mr. & Mrs. Thomas
C. Freyman
Ms. Harriet Friedly
Friends of Cancer
Research
Friends of the Hospital
Friends of the University
Mr. Alexander P. Frigo
Friman & Stein, Inc.
Roger & Madelon Fross
Mr. & Mrs. Don E. Fuller
Mr. & Mrs. Donald M. Fyfe
Ms. Dorothy H. Gaertner
Mr. & Mrs. William Gaffin
33
Ms. Karen H. Gaines
Mr. John Galambos
Mr. Charles J. Gallagher
Ms. Marion L. Gallagher
Mr. Patrick Gallagher
Mr. Salvador Garcia
Mr. & Mrs. Glenn Garfinkel
Mr. & Mrs. Ron Garfinkle
Ms. Martha L. Garrett
Ms. Catherine L. Garvey
Mrs. Patricia C. Garvy
Mr. & Mrs. Ben Gatch Jr.
Mr. & Mrs. Joseph
J. Gauthier
Ms. Florence M. Gavin
Mr. & Mrs. Michael
J. Gaylor
Mrs. Martha F. Gearhart
Ms. Patricia Gebler
Mr. William Gee
Mr. & Mrs. Larry
G. Geer Sell
Gehring Remodeling
Company
Mr. & Mrs. Gary Geiger
Mrs. Judy Geleerd-Kitzes
Ms. Rachel Genduso
Gentle Dental Care, P.C.
Mr. & Mrs. William
C. Gentry
Geocaris Law Firm
Georgetown University
Ms. Susan Geraghty
Mr. & Mrs. Frederick
J. Geyer
Mr. & Mrs. David
M. Gibbons
Mr. Brian P. Giesche
Mr. & Mrs. Laurence M. Gill
Mr. R. Scott Gill
Ms. Kathleen Gilmore
Eric Ginsburg
Ms. Rochelle Ginsburg
Mr. Robert F. Girgis
Ms. Ruth G. Glassenberg
Ms. Margaret Glesche
Mr. & Mrs. Michael
Glickman
Ms. Teresa B. Glotzbach
Mr. & Mrs. E. Richard
Goddard
Ms. Erika Goeckner
Mr. Langer Gokey
Mr. Steve J. Erd & Ms.
Stacey Gold Erd
Mrs. Jill Scheffler
Goldhamer
Mr. Dennis K. Goldman
Mr. Anthony Golobitsh
Mrs. Carol Gonsky
Mr. James B. Goodman
Mr. & Mrs. Joe Goodwin
Ms. Tara L. Goodwin
Mr. Edward T. Gordon
Gorter Family Foundation
Mr. & Mrs. Howard
Gossage
Mr. Norman Gotteiner
Caryl Gout
Mr. William A. Grabow
Mr. & Mrs. T.
Randall Graeb
Ms. Lisa Granbur
Ms. Judy A. Grant
Mr. & Mrs. Gerry Gravina
Steven & Chandra Gray
Ms. Lisa Greenberg
Mr. & Mrs. Gerson
Greenburg
Mr. & Mrs. Ronald
Greenspon
Ms. Lydia Gregoret
Mr. Jeff Grimes
Mr. & Mrs. Jeff Gromos
Ms. Wendy S. Gross
Ms. Carrie Groszek
Mr. & Mrs. Dennis Grover
Mrs. Mary Lewis D. Grow
Mr. Roy Grow
Ms. Jeanne M. Gruhlke
Mr. Gilbert R. Guajardo
Mr. & Mrs. Hem C. Gupta
Mr. & Mrs. David J. Gurin
Mr. William Guswiler
Ms. Jean Haas
Ms. Susan Hagaman
Mr. & Mrs. Guy E. Hagen
Ms. Marilyn L. Hagler
Mr. Bruce Hague
Mr. & Mrs. Brian Hahn
Hair Watchers
Boutique Plus
Ms. Bernice L. Hajduk
Melina Hale
Mr. Joel D. Halper
Mr. Jan Douglas Halverson
Mr. Michael D. Halverson
Ms. Sharon R. Hamilton
Reverend & Mrs.
Robert C. Hamm
Dr. & Mrs. Raymond
M. Handler
Dr. & Mrs. Jonathan
A. Handler
Ms. Judith F. Hanrahan
Ms. Carol J. Hansen
Ms. Peggy Rose Hanson
Mr. James Hantak
Mr. Kent G. Harbison
Mr. Russell M. Harden
Mr. Karl R. Hardiman
Ms. Beaty R. Harris
Mrs. Gwen Harris
Mr. Morton J. Harris
Mrs. Sheldon Harris
Ms. Sara A. Hart
Mr. Jeff Harting
Ms. Margaret Hartney
Mr. & Mrs. Michael
J. Harvey
Jeff Harvey & Julie Shelton
Mr. & Mrs. Stephen
J. Hauer
Mr. Lionel Hawkins III
Mr. & Mrs. Brian P. Hayes
Ms. Judith B. Hayman
Mr. & Mrs. James T. Hayner
Ms. Mary M. Healy
Mr. & Mrs. Charles
G. Hearn
Mr. Jeff Heddles
Mr. & Mrs. F.F. Hedrick Jr.
Mr. James Heffernan
JoAnne Heffernan
Mr. Christopher K.
Hehmeyer
Mrs. Martha Heisel
Dr. & Mrs. Javad
Hekmatpanah
Mr. Eric Helfand
Mr. & Mrs. David B. Heller
Ms. Anne Hellmer
Mr. Michael J. Czarnecki
Ms. Lesli K. Henderson
& Mr. Steven
Robert Goldman
Mr. & Mrs. Jack A.
Henderson
Mr. & Mrs. Dylan
A. Hengstler
Mr. Richard C. Hennessy
Herbst Financial
Advisors, Inc.
Ms. Pamela Hernandez
Ms. Lorraine Herr
Mr. & Mrs. Chad Herring
Mr. & Mrs. Jerry Hersh
Mr. & Mrs. Robert Hess
Ms. Beverly J. Heydinger
Mr. Charles M. Hicks
Ms. Katherine Hidaka
Mr. & Mrs. Elzie
Higginbottom
The Highland Park
High School Athletic
Department
Mr. Steven A. Hild
Mr. & Mrs. Brian G. Hinds
Mr. James J. Hipp
Ms. Lindy Hirschsohn
Ms. Brooke Hittler
Mr. & Mrs. William Hoefs
Mr. William V. Hogan
Mr. & Mrs. Donald
G. Holland
Mr. Kurtis Holle
Ms. Frances M. Hollister
Ms. Lorraine Hollister
Mr. Mark E. Holstius
Mr. Sheldon P. Holzman
Homewood Flossmoor
Soccer Club
Donations
Support:
Research
into the
relationship
between
hormone
signaling and
cancer stem
cell genes that
will lead to new
strategies to
prevent, detect,
and treat
prostate cancer.
* Deceased
Donations
Support:
Resource Center
for storage and
dissemination of
research-quality
tissue for the
complex genetic
analyses
necessary
to develop
innovative,
personalized
cancer therapies.
Mr. & Mrs. William L. Hood
Mrs. Susan R. Hoogland
Ms. Barbara R. Hooper
Mr. David B. Hooper
Hoosier State Press
Association, Inc.
Ms. Sandra Horberg
Mr. Peter Horemiotes
Mr. & Mrs. Mark Hornok
Mr. & Mrs. William
E. Horowitz
Mrs. Walter G. Horschke
Mr. Jeffrey M. Hortsch
Hospira Employee
Giving Campaign
Hour of Power
Ms. Carol H. Houston
Mr. James R. Burket & Mrs.
Kathleen Howe-Burket
Mr. & Mrs. Richard
Howenstine
Mr. John Dun-Lu Huang
Mr. Jonathan Huff
Ms. Christy Hughes
Mr. Michael Hughes
Ms. Lois Hummel
William B. & Melanie
S. Hummer
Li Fang Hung
Hunter Douglas
Metals, Inc.
Mr. Stanley Hurd
Arti Hurria
Ms. Joseph Hynek
Lynette M. Iannantuoni
& John E.
Iannantuoni, SB’63
IBM Corporation
ICMEA
Ms. Jacqueline H. Ieuter
The Jaffee Foundation
The Illinois Organization
of Mothers of
Twins Club, Inc.
Mrs. Vera L. Imhoff
Mr. & Mrs. Mario Imparo
Mr. & Mrs. Donald
K. Inderlied
Industrial Services of
America, Inc.
Mr. Robert A. Ingram
INT
Interglobal Design Inc.
International Brotherhood
of Electrical Workers
Mr. Sultan S. Issa
ITW Foundation
Mr. Salvatore Iuliano
J & J Newell Concrete
Contractors, Inc.
J. P. Morgan Chase
Foundation
Ms. Lynn A. Jachec
Mr. Zach Jacobs
Ms. Claudia Jacobson
34
Ms. Irit Jacobson
Mr. John E. Jacobson
Mr. & Mrs. Perry Jager
Mr. & Mrs. Rich
Jakubowski
James & Hoffman
Mr. Edgar J. James
Ms. Elizabeth Janairo
Mr. & Mrs. Keith R. Jans
Mr. & Mrs. James
R. Janssen
Mr. Dean Jarog
Sidney F. Jarrow
Jean Haas, Inc.
Ms. Katherine Jenal
Ms. Mary Jenal
Ms. Nancy Jenal
Mr. Robert Jenal
Mr. Steven Jenal
Mrs. Linda L. Jennings
Ms. Hilary Jensen
Joel Kennedy Constructing
Corporation
Mr. & Mrs. Joseph Johnson
Mr. & Mrs. Bruce Johnson
Ms. Mary Johnson
Mr. & Mrs. Michael
Johnston
Mr. Norman M. Johnson
Ms. Vivian L. Johnson
Mr. & Mrs. Jonathan
G. Jollief
Ms. Dolores Jones
Mr. & Mrs. Richard
E. Jones
Mrs. Pam Jones
Ms. Sandra Jones
Mrs. Adele K. Joseph
JRP Properties LLC
Mr. Alan R. Juraska
Ms. Marija Jurcevic
Mr. & Mrs. Daniel Jurovich
Ms. Lois Just
Mr. & Mrs. Clark Justice
Mr. & Mrs. Lawrence
I. Kahn
Mrs. James Kahnweiler
Ms. Irene Kaim
Mr. George M. Kaiser
Mr. Hunter Kaiser
Mr. Nick Kakos
Mr. Donald J. Kallin
Ms. Sandra Kamin
Ms. Marci Kaminsky
Ms. Kristi Kangas
Mr. Scott Allen Kappmeyer
Mr. & Mrs. Joseph Karacic
Mr. & Mrs. Jim Karalekas
Karl Knauz Motors
Mr. & Mrs. William
D. Kasdorf
The Kamin Foundation
Mr. David Kass
Ms. Angela Katinas
Mr. & Mrs. Paul Katsabanis
Mr. Larry B. Katzbeck
Mr. David Kaufman
Mr. & Mrs. William
Kaufman
Mr. & Mrs. Robert
W. Kaufman
Ms. Marcia A. Kay
Mr. Richard Kaylor
Ms. Sheila Keane
Mr. Joseph S. Kearney Jr.
Ms. Ann Keating
Ms. Bonnie Keeler
Mr. Patrick J. Keenan Jr.
Kathryn Keenan
Mr. Patrick Keenan
Mr. & Mrs. Art Keister
Mr. Kevin Keleghan
Mr. & Mrs. Dan Kelleher
Ms. Natalie M. Keller
Mr. Daniel J. Kelley
Mr. Donald J. Kelliher
Ms. Mary T. Kelly Hanson
Ms. Lara G. Kelly
Ms. Jennifer L. Kennelly
Ms. Annette Kenney
Ms. Margaret Kenny
Mr. Andy Kenoe
Mr. & Mrs. Richard Kerner
Ms. Helen Kerrigan
Ms. Caroline Khadder
Mrs. Jodi Ann Khan
Ms. Mary Kiener
Ms. Patricia J. Kilcullen
Kipnis Rosen & Bloom Ltd
Mr. & Mrs. W. J. Klawitter
Mr. Fred Klein
Ms. Laura Klement
Mrs. Catherine V. Knapp
Ms. Susan Knight & Mr.
Lawrence H. Jones
Mr. Fred Lamar Kniss
Ms. Megan Knott
Mr. Thomas Knott
Mr. Michael S. Jacobs &
Mrs. Kirbie J. Knutson
Ms. Suzanne K. Knutson
Mr. Eric Kobe
Mr. Eric Kodish
Ms. Isabel M. Kodron
Mr. & Mrs. Joseph E. Kolar
Mr. Michael Kolleng
Mr. Douglas C. Kolsrud
Mr. & Mrs. David Komiss
Mr. & Mrs. Bernard
Kompare
Mr. & Mrs. George
Kontogiannis
Mr. Thomas J. Koplos*
Ms. Burdette Koran
Ms. Pauline A. Kosmitis
Mr. Michael J. Kowalewski
cancer.uchicago.edu
Ms. Marla L. Kowalski
Mr. Edward Koznarek
Mr. & Mrs. Demetrios
L. Kozonis
Kramer Enterprises
Ms. Kelly G. Krantz
Mr. & Mrs. Roderic Krapf
Ms. Martie Krassek
Mr. Jeffrey Krause
Cory Krebsbach
Ms. Peggy Kreisman
Ms. Debra H. Kretzmann
Ms. Stella Kriaras
Ms. Esther
Krick-Woodward
Ms. Rosemary Kriener
Ms. Karen C. Kristofik
Ms. Barbara Kriyger
Mr. & Mrs. Larry Krueger
Mr. & Mrs. Robert G. Krug
Mr. & Mrs. Mark
Krumtinger
Mr. & Mrs. Kenneth
Krupinski
Ms. April M. Krydynski
Ms. Joy H. Kuchler
Ms. Linda Kuczka
Mr. & Mrs. Steven J. Kuehl
Mr. John A. Kuhlman
Ms. Azra Kulasa
Ms. Maureen Kunze
Mr. & Mrs. Bud
Kuppenheimer
Ms. Judith Klemke Kurzeja
Ms. Agnes Yao Kwan
Ms. Laurian E. Kyritz
Mr. James Lagerhausen
Ms. Mari Meyer Lagone
Mr. & Mrs. Hristos
A. Lalopoulos
Ms. Edward Lam
Ms. Jane B. Lambesis
Ms. Shirley Land
Mr. Arthur P. Langendorff
Mr. & Mrs. Alan Langerud
Ms. Penfield S. Lanphier
Mr. Alvin Lapper
Mr. & Mrs. Richard
C. Larsen
Mr. & Mrs. Richard
D. Larson
Mr. Arthur Laschober
Ms. Nancy Laser
LaSota Investments, Inc.
Mr. John LaSota
Mr. & Mrs. James
O. Latturner
Mr. Michael J. Lauesen
Law Offices of
Daniel J.Kelley
Ms. Cherilyn K. Lawrence
Mr. Richard E. Lawrence
Ms. Linda L. Lawson
Dr. Richard B. Lazar &
Ms. Jessica E. Tampas
Mr. & Mrs. Larry L. Leadley
Mrs. Mary E. Lebbin
Dr. Michelle M. Le Beau &
Dr. Robert Harwood
Dr. & Mrs. Kwang-Sun Lee
Ms. Sarah Lee
Ms. Dawn Lehmann
Ms. Julie M. Leider
Lemont Family Dental, LTD
Ms. Kristina Leng
Mr. Matthew B. Lerner
Mr. & Mrs. Tom Les
Ms. Pamela Lesinski
Mr. John Lessick
Mike & Susan Levine
Dr. Robert L. Levy
Ms. Jacqueline
James Lewis
Mrs. Janet G. Lewis
Mr. & Mrs. Steven H. Lewis
Mr. & Mrs. Jon J. Lewis
Ms. Denise Leyland
Ms. Hazel L. Liebling
Mr. Curtis W. Lieneck
Ms. Marjorie Lieneck
Dr. Stacy Tessler Lindau
& Dr. Peter Lindau
Mr. & Mrs. Carl J.
Lindeberg
Ms. Morgan Lindsay
Mr. David J. Lionett
Lions Club of Chicago
Heights
Mr. Jack L. Lipson
Ms. Jennifer B. Lipson
Ms. Julia Lissner
Mr. Peter Litt
Mr. Chester A. Lizak
Ms. Nancy LoBue
Lockport Fire Fighters
Local 1544
Mr. & Mrs. John H. Loecke
Mrs. Linda H. Loewenstein
Mr. Anthony N. Logan
Mr. Ernest Lohmar
Ms. Mary Long
Lora Lei Acres
Homeowners
Association
Mr. Stanley R. Losinski
Mr. Martin Low
Mr. Stephen I. Lucas
Ms. Danielle Luisi
Mr. & Mrs. Mark
Norman Lundgren
Mr. John W. Lute
Luther College
Mr. Earl Lyden
Mr. William R. Lyman
Mr. & Mrs. Robert J.
Machovec Jr.
Ms. Heather J. Macklin
35
Madison Dearborn
Partners, Inc.
Mr. James Maggio
Ms. Susan H. Maher
Dr. Naznin A. Mahmood
Ms. Ann Marie Malbeuf
Mrs. Marci A. Malter
Mr. & Mrs. David C. Manck
Mr. James J. Mandarino
Mr. & Mrs. Irwin B. Mandel
Meredith Manni
Ms. Barbara A. Manny
Mr. & Mrs. Polyxeni
Mantzakides
Mr. & Mrs. Stephen
P. Manus
Mr. & Mrs. Nicola
C. Manuzzi
Mr. Kent A. Marburger
Mr. & Mrs. Richard
W. Marco
Ms. Eve Marek
Mr. Stephen P. Mares
Ms. Mildred Margenau
Mr. Daniel J. Marhigiani
Ms. Sandra K. Marinucci
Mr. Peter L. Markos
Ms. Anna K. Marks
Ms. Elizabeth Mars
Mr. & Mrs. Daniel A. Marsh
Mr. & Mrs. Thomas
R. Marsh
Mr. & Mrs. Alan Martin
Mr. & Mrs. Jack W. Martin
Ms. Laura Martin
Dr. Lisa Anne Martin
Ms. Mary C. Martindale
Ms. Patricia Martindale
Mr. & Mrs. Ronald
A. Marwitz
Mary Garrison Interiors
Mr. & Mrs. Salvatore
Massanisso
Mr. & Mrs. James T.
Massimilian
Mr. & Mrs. Steven D. Masur
Mrs. Evelyn Matasar
Ms. Patricia Ann Mathis
Mr. Nathan Z. Matisse
Mr. John W. Matkey
Mr. Zachary Matlin
Ms. Beverly A. Matre
Mr. & Mrs. Edward
K. Matteson
Ms. Suzanne Matthies
Mr. & Mrs. Isaac Mayefsky
Mrs. Terese O. Mayer
Ms. Suzanne M. McArdle
Mr. & Mrs. Thomas
R. McBreen
Ms. Christine A. McCabe
Ms. Jacquelyn McCanse
Mrs. Mary McCarthy
Joan Q. McClellan
Mr. Mark C. McCloy
Ms. Pamela A. McCord
Mrs. Tammy J. McCormick
Mr. & Mrs. Adam
M. McCostlin
Ms. Virginia A. McDivit
McDonald Hopkins LLC
Ms. Elizabeth E. McDonald
Mr. Robert U. McDowell
Mr. Charles L. McElveen III
Robin Josephs McGarvey
& Patrick McGarvey
Ms. Carol A. McGuff
Mr. Thomas Clement
McGuigan
Mr. Eric G. McGuire
Ms. Georgianna S. McGuire
Mrs. Michelle M. McGuire
Ms. Margaret S. McInerney
Mrs. Nora Groh McKinley
Mr. & Mrs. Martin
J. McKinney
Timothy McKula
Ms. Rachel Monica
McLaughlin
Dr. Ronald W. McLawhon
Ms. Janet F. McNair
Ms. Marianne E. McNulty
Mr. Don McQuilkin
The McWethy Foundation
Mecox Illinois, Inc.
Mr. & Mrs. Marcus Meinzer
Menalon Society
Chapter 26
Ms. Eva Mergner
Ms. Amy Merrick
Ms. Meredith L.
Manni Meserow
Mr. & Mrs. Paul S.
Messerschmidt
Ms. Fleta F. Metcalf
Ms. Judy A. Metcalf
Mr. Philip L. Metcalf
The Metron Group, Inc.
Mr. Dale L. Meyer
Mr. Eric Meyer
Ms. Heather Meyer
Ms. Jean F. Meyer
Middlebury College
Ms. Nicole M. Middleton
Mr. & Mrs. Mark T. Mikita
Ms. Catherine Miller
Ms. Judy A. Miller
Ms. Lana T. Miller
Ms. Mary V. Miller
Mr. & Mrs. Michael Miller
Ms. Ashley Misenheimer
Mr. & Mrs. Edward
M. Miskell
Sucheta Misra
Dr. Bryan R. Mitchell*
Mr. & Mrs. William
T. Modrak
Ms. Sara Moffitt
Mr. Syed Mohiuddin
Mr. Michael M. Mollin
Ms. Lavergne T. Moman
Ms. Karen D. Monroe
Ms. Roberta J. Monroe
Ms. Sonya Monroe
Mr. Richard Grunsten
& Ms. Dehn
Moon-Grunsten
Ms. Megan Moore
Ms. Janet C. Moran
Ms. Mariah E. Moran
Mr. & Mrs. Leo Morand
Ms. Christine A. Mordach
Ms. Jean E. Morfas
Mr. Geyer Morford
Mr. & Mrs. Michael
C. Morgan
Mr. James A. Morman
Ms. Wilda W. Morris
Ms. Niki J. Morrison
Mr. Thomas E. Morrison
Ms. Vivian Morton
Mr. Kevin Mosley
Mr. Sam’s Transportation,
Inc.
Mueller Funeral Homes
Mr. Michael Mullen
Ms. Margaret L. Mullin
Mr. & Mrs. William
E. Mullin
Ms. Helen Mulopulos
Multimedia Sales &
Marketing Broadcast
Services
Mr. & Mrs. Timothy
M. Mundt
Mr. Thomas G. Murphy
Ms. Jennifer Myerberg
Mr. Frederick J. Nachman
Dr. James Nachman*
NASA/Wildcat
Booster Club
National Philanthropic
Trust DAF
Ms. Mackinzie Neal
Mr. & Mrs. John D. Neef
Mr. Richard Neely
Mr. & Mrs. Stanley Neimark
Mr. & Mrs. Gary M. Nejedly
Mr. Andrew Nelson
Mr. David D. Nelson
Mr. Howard Nelson
Ms. Jeannette A. Nelson
Neo Kyma Messinias
Mr. Brad H. Neuman
Nevada Direct Insurance
Company
New Trier High School
Boys Swimming/Diving
Cary Newell
Vicki Newell
Diane B. Newman
Mr. Gordon H. Newman
Donations
Support:
New, one-of-akind program
that focuses on
the emerging
field of cancer
economics.
* Deceased
Donations
Support:
The acquisition of
a cyclotron and
development of
a radiochemistry
program that will
help speed the
advancement
of personalized
medicine.
Mr. & Mrs. Melvin Newman
Mr. Raymond T. Nice
Mr. John R. Nickel
Mr. William Nicolai
Ms. Hanna Niewiarowski
Mr. Richard S. Nikchevich
Mr. Christopher Niro
Thomas P. Noonan
Ms. Susan L. North
Mr. William L. North
The Northern Trust
Company
Northwestern Il Bridge
Association
Ms. Carol Polk Norton
Ms. Catherine Norton
Mr. & Mrs. Timothy
J. Notaro
Mr. Jeffrey C. Novak
Ms. Virginia S. Novak
Ms. Carol Ann Novick
Ms. Mary F. Novick
Mr. & Mrs. Fred S. Novy
Nutter, McClennen
& Fish, LLP
Mr. James E. Nyeholt
Mr. & Mrs. John A. Oaks
Ms. Laura O’Brien
Ms. Marilyn J. O’Brien
Mr. & Mrs. Daniel
M. O’Brien
Mr. Phillip O’Brien
Mr. Roger O’Brien
Ms. Ann Marie O’Connell
Mr. William J. Donewald
Ms. Cathie M. O’Donnell
Ms. Nancy E. O’Donnell
Mr. & Mrs. Cole Oehler Jr.
Mr. & Mrs. William
J. Ohlhaber
Ms. Susan Okin
Ole Henriksen of
Denmark, Inc.
Ms. Katelyn Olewinski
Mr. Lawrence Olewinski
Ms. Elizabeth Olson
Omnivore Books on Food
Mrs. Cathryn M. Onak
Dr. Kenan & Dr. Karen Onel
Ms. Nadia F. Ori
Mr. James G. Orphan &
Mrs. Irene A. Orphan
Mr. Daniel J. O’Shea
Ms. Tracy Oshita
Mr. Raymond Osowski
Mr. & Mrs. Terrence
P. Ostrowski
Overland Metals, LLC
Mr. & Mrs. Stephen Paczolt
Mr. & Mrs. Stephen B. Page
Ms. Patricia E. Page
S. Margaret Paik, MD
Mr. & Mrs. Robert Palay
36
Mr. & Mrs. James Palilonis
Mr. & Mrs. Jeffrey
S. Palmer
Ms. Marion T. Palumbo
Ms. Kathy
Panagakis-Laurisch
Mr. Kevin Pang
Mr. John M. Panicek
Mr. James Papajohn
Mr. & Mrs. Donald
G. Papenburg
Mr. & Mrs. Gust J. Pappas
Ms. Eleftheria Pappas &
Mr. Fotine Parzygnot
Mr. & Mrs. Alberto Pappo
Mr. Richard Park
William B. Parker, MBA’78
Ms. Lena Parsons
Ms. Robin Parsons
Mr. & Mrs. Brian
W. Patterson
Ms. Janet Paulson
Mr. Jeffrey Scott Pavlik
Lucio Pavone
Dr. & Mrs. Sachin Pawar
Mr. Jack Payan
PCNation
Mr. & Mrs. Kirby Pearson
Mr. J. Marshall Peck
Ms. Lee Peck
Mr. Robert E. Pence
Mr. & Mrs. Kenneth
L. Pendery Jr.
Mrs. Kelley A. Pennington
Pentair Residentail
Filtration, LLC
Mr. Ramon M. Perez
Mr. & Mrs. Randall
W. Perkins
Ms. Bridget Perlmutter
Ms. Patti A. Perlock
Dr. & Mrs. Eduardo Perozo
Terry L. Pesek
Peter Snelten & Sons, Inc.
Ms. Lily Peter
Mr. Steve Peters
Ms. Carol Petersen
Ms. Lauren G. Peterson
Ms. Missy Peterson
Ms. Kristi Phelps
Ms. Terry Philips
Physicians Sports &
Injury Center, Inc.
Mr. & Mrs. Orren T. Pickell
Ms. Hanna T. Piech
Ms. Linda M. Pierce
Mr. William S. Pilawski
Mrs. Jennifer Pingle
Mr. Daniel Pinkert
Mr. Kirk Alan Pinkerton
Pircher, Nichols & Meeks
Mr. Gene E. Pitzer
Mr. & Mrs. John J. Piva Jr.
Plainfield Moose Family
Center # 2491
Mr. & Mrs. Craig Planson
Mr. & Mrs. Clarice
S. Pleiter
Mr. Paul Pokrifcak
Ms. Barbara Polito
Mr. & Mrs. William M. Pond
Mr. Frank Ponterio
Ms. Ruth M. Poparad
Ms. Phyllis Popek
Mr. Steven G. Poskanzer
Mr. Eric Postpischil
Mr. & Mrs. Angelos Potakis
Ms. Barbara F. Potter
Mr. & Mrs. Nicholas
Poulopoulos
Ms. Bess Poulos
Mr. Dimitri J. Poulos
Dr. John D. Poulos
Mr. & Mrs. Sam Prassinos
Dr. Irwin Press & Mrs.
Andrea S. Press
Ms. Victoria Pressling
Mr. Gary Prestopino
Kira Aberle Price
Mr. Kyle Price
Mr. Richard A. Price
Mr. & Mrs. Greg Pritchard
Mr. Scott Probst
Ms. Pranitha V.
Prodduturvar
Ms. Catherine M. Prullage
Mr. Stanton E. Puck & Ms.
Claudia R. Belshaw
Ms. Marie P. Queenan
The Queenan Foundation
Mr. John Quigley
Ms. Kristin Quinn
Ms. Doloris A. Radke
Mr. & Mrs. Michael J. Rahn
Mr. & Mrs. Walberto Ralon
Ms. Yvonne Ralsky
Mr. & Mrs. Gordon Ramig
Mr. Joe L. Raudabaugh
Ray Allen Inc.
Raymond James
Financial, Inc.
Mr. Seth Noah Reagen
Ms. Kelly Redmond
Mr. & Mrs. Mark B. Reed
Renee Rehkemper &
Jeffrey Rehkemper
Mr. Bradley Reiff
Mr. & Mrs. Mark M. Reilly
Mr. Gordon Reinhertz
Reinhold & Lucille
Groh Foundation
Mr. Robert L. Reiser
Mr. Carl Reiter
Mr. Harvard Reiter
Ms. Ann Rentschler
Mr. Alexander Reo
cancer.uchicago.edu
Ms. Mary Jane Resendiz
Mr. Mark Reshkin
Restorative Dental
Laboratory
Mr. & Mrs. Demetri
J. Retson
Mr. & Mrs. Michael
J. Revord
Mary S. Reynolds
Mr. Thomas F. Reynolds
Ms. Ann Rezabek
Mr. Samuel L. Rhone
Mrs. Lynn D. Rice
Dolores Richert, AM’66
Mr. & Mrs. David
Riesmeyer
Ms. Marilyn A. Riley
Susan M. Riley
The Risk Management
Planning Group, Inc.
Mrs. Burdette E. Ristenpart
Mr. & Mrs. Milorod Ristich
Dr. & Mrs. Ralph Robbins
Roberts Salvage, Inc.
Ms. Stacy Roberts
Ms. Kimberly J. Robinson
Mr. & Mrs. Francis Roche
Mr. Thomas F. Rochford
Mr. & Mrs. Stanley
R. Rodgers
Mr. Harold Rodin
Astrid Rodriguez
Mr. Donald L. Rogers
Mr. Hector A. Rojas
Dr. Brian B. Roman
Mr. Michael Romano III
Mr. Maya Romanoff
Ronald Rubinstein Ltd.
Mr. & Mrs. Frank Ronis
Mr. Gerald L. Ronspies
Harry B. & Francine
Rosenberg
Ms. Marlene Rosenberg
Mr. & Mrs. Philip R.
Rosenblatt
Dr. Marsha Rosner &
Dr. Robert Rosner
Ms. Jean L. Ross
Mr. & Mrs. Joel M. V. Roth
Huron Consulting Group
Dr. Clare K. Rothschild
Mr. David Rothstein
Mr. Seymour Rothstein
Mr. & Mrs. Philip R. Rotner
Mr. Gus M. Rousonelos
Dr. & Mrs. Charles Rubin
Mr. & Mrs. Frank R. Rubino
Mr. Gerald J. Rudman
Mrs. Howard Rudolf
Mr. & Mrs. Richard
S. Ruffolo
Ms. Jennifer Rumbach
Mr. & Mrs. John A.
Rumbach
Mr. & Mrs. Bob Rumbach
Mr. Paul T. Rumbach
Mr. & Mrs. Jack Rusher
Mr. & Mrs. Gerald Russ
Mr. Kemper Ryan
Mr. William R. Rybak
Ms. Joyce A. Ryburn
Mr. Satish K. Sachdev
Ms. Lisa Sagami
Mrs. Loretta Salata
Mr. Ron Salerno
Mr. Andy Salk
Mr. David L. Saloom
Mr. & Mrs. Jerrold
E. Salzman
Mr. Sherley Sampson
Mr. & Mrs. Thomas
H. Sampson
Mrs. Ellyn F. Samsky
Ms. Marian J. Samstag
Regina Sandberg
Mr. Calvin Sanders Jr.
Mrs. Marjorie Sandlow
& Mr. Barry S. Rosen
Mr. & Mrs. Mark Saran
Ms. Judith E. Sarnat & Ms.
Gail D. Zimmerman
Ms. Janet K. Sarsh
Ms. Bonnie J. Sartore
Mr. James F. Sarwark
Ms. Suzy Satterlee
Mr. & Mrs. Jamie Saucedo
Mr. & Mrs. James H. Saum
Ms. Janelle M. Savage
Ms. Judith Saville
Ms. Sharon Sawallisch
Mr. & Mrs. James
W. Scanlon
Mr. & Mrs. David
J. Schachner
Lawrence W. Schad
Mr. & Mrs. Ingo Schaefer
Ms. Kelly A. Schaefer
Ms. P. J. Schaffer
Mr. Robert P. Schaible
Mr. & Mrs. Joel R. Schaider
Mr. Sheldon Schak
Ms. Alice K. Scheffler
Mrs. Milton M. Scheffler
Mrs. Carol Schempp
Mr. & Mrs. Larry
J. Schibilla
Mr. & Mrs. Theodore
J. Schiff
Schiffer Publishing, Ltd.
Mr. & Mrs. Adam
R. Schimel
Ms. Bayla Schimmel
Ms. Sara Schimmel
Mrs. Judy Schleisman
Mr. & Mrs. Robert L.
Schlossberg
Mr. & Mrs. John R. Schmidt
Mr. & Mrs. Frank Schmitz
37
Mr. & Mrs. Howard M.
Schoenberger
Mr. & Mrs. William
Schoettler
Ms. Anne Schreiner
Mr. & Mrs. Richard
A. Schuberth
Mr. & Mrs. Steve Schuler
Mr. Floyd A. Schultz
Mr. Matthew Mason Schulz
Mrs. Cathy Schulze Coll
Mr. & Mrs. Robert
L. Schum
Mr. & Mrs. William
Schuman
Ms. Kathy Schwartz
Mr. & Mrs. Michael
R. Schwartz
Ms. Orit Schwartz
Mr .& Mrs. Richard
D. Schwartz
Ms. Linda Schwartzman
Ms. Barbara A. Scieszka
Mrs. Carol A. Scott
Mr. Paul Scott
Mr. & Mrs. Francesco
Scozzaro
Mr. E. Preston Scruggs II
Ms. Christine M. Seber
Mr. & Mrs. Stephen
P. Seder
Mr. & Mrs. Andy Sedlacek
Mrs. Frances R. Seidman
Mr. David R. Selmer
Dr. Charlene Sennett
Mr. Bernard Settler
Seymour J. Bagan Trust
Shagufta Shabbir
Mr. & Mrs. Harold
Shabelman
Ms. Rupali Rajendra Shah
Ms. Karen Shah-Mirany
Mr. & Mrs. Alan Shalette
Mr. Edwin Shangerg
Lester & Edna Shapiro
Family Foundation
Sharpe Well Drilling
Ms. Lillian R. Sharpe
Mr. & Mrs. Neil J. Sheehan
Sherman Media
Company, Inc.
Mr. Harry Sherman
Mr. Lawrence A. Sherman
Ms. Muriel Horn Sherman
Mr. Young J. Shin
Mr. & Mrs. Lloyd G. Shore
Mr. Reuben Shore
Mr. Norman Shubert &
Mrs. Carol Shubert
Mr. Frank L. Sibr Jr.
Siegel Decorating
Company
Mr. Anthony J. Siegel
Ms. Lauren Siegel
Mrs. Elizabeth Sigler
Ms. Jane Siklos
Ms. Judy Sikora
Mr. & Mrs. Jerry G. Silbert
Silver, Lerner, Schwartz
& Fertel
Mrs. Elizabeth H.
Silverman
Mr. & Mrs. Gary Silverman
Mr. Joseph V. Simeri
Mr. Adam Simon
Barbara & Michael Simon
Ms. Nicole Simon
Ms. Krishna Simonetti
Mr. Terrico Simpson
Ms. Leora Sims
Mr. Richard Sinkuler
Mr. & Mrs. Clive Sirkin
Ms. Jean P. Skellchock
Mr. & Mrs. Thomas
John Skelly
Mr. & Mrs. Gus P. Skizas
Mr. & Mrs. Martin Skoglund
Ms. Luanne Skow Ttee
Karen Slimmon,
MBA’91 & Andrew
Slimmon, MBA’91
Ms. Wendi Elizabeth Sloane
Ms. Anne R. Smith
Ms. Emily K. Smith
Mr. & Mrs. Gregory Smith
Ms. Kristina Smith
Mr. Melvin H. Smith
Dr. Ralph H. Smith Jr.
Mr. & Mrs. Robert K. Smith
Mr. Ronald Smith
Mr. A. W. Smithberger
Mr. & Mrs. Edward
J. Smosna
Ms. Barbara Snidanko
Ms. Donna Sobotka
Gwen Solberg
Mr. & Mrs. Gary Solomon
Mr. & Mrs. Leonard
H. Solomon
Ms. Yekaterina L. Soloviov
Mrs. Janie Song &
Dr. David Song
Mr. Chung Song
Mr. Alan H. Sons
Ms. Anne Sorock
Mr. & Mrs. Vasilios T. Sotos
Ms. Kiki Sotos
Mr. & Mrs. Steve Sowski
Speedway Auto Parts, Ltd.
Mr. & Mrs. John S. Spegal
Ms. Roslyn Spellman
Mr. Earl L. Spencer
Mr. & Mrs. Thomas Spitz
Ms. Eileen Sprague
Springfield Lakeshore
Improvement
Association
St. Mary Immaculate Parish
Ms. Colleen Stachon
Ms. Joan M. Stader
The Stauber Family
Foundation
Ms. Barbara A.
Stamper-Stevenson
Standard Bearers Class
Markle Church
Ms. Marilynn Stanish
Starks & Menchinger
Family Funeral Home
Ms. Kimberly G. Starman
Ms. Cathy Stathakis
Mr. & Mrs. William
S. Stavros
Mr. & Mrs. Harry Stavros
Ms. Sarah Stefan
Ms. Dolores Stefanisin
Mr. & Mrs. Richard
J. Stefanski
Mr. & Mrs. David Eric Stein
Mrs. Gail Stein
Ms. Lisa G. Stein
Mr. Ronald D. Stenger
Mr. Allan J. Sternstein
Ms. Nancy P. Stevens
Ms. Gail Stewart
Ms. Joanne T. Stewart
Ms. Kim Stiffle
Ms. Danielle Stone
Mr. & Mrs. Joseph L. Stone
Ms. L. Susan Stone
Ms. Susan L. Stone
Mr. & Mrs. Harold
V. Stotland
Mr. & Mrs. Peter C. Stott
Mr. & Mrs. Edward
J. Stransky
Strategic Custom
Builders Inc.
Ms. Marilyn K. Straus
Mr. Richard A. Strauss
Mr. Edward D. Streicker
Ms. Jennifer L. Stull
Ms. Marsha L. Stull
Mr. & Mrs. Mathew J. Stuve
Mr. Scott Suckow
Sullivan Family Fund
Mr. Dennis M. Sullivan
Ms. Linda Sullivan
Ms. Lori T. Sullivan
Ms. Mary P. Sullivan
Mr. Thomas J. Sullivan
Ms. Nancy Sulok
Ms. Gabriela N. Sunga
Susan & Marvin Dickman
Family Charitable Trust
Ms. Beverly Sussman
Ms. Alessandra Vavas
Swanson
Ms. Gwen E. Swanson
Peggy B. Swartchild
Mrs. Olga Swiontek
Ms. Elizabeth K. Szabo
Donations
Support:
Research to
identify genetic
variants that
will help
determine
which patients
will respond
best to
certain cancer
treatments.
* Deceased
Donations
Support:
Pediatric
cancer research
at UChicago’s
Comer Children’s
Hospital.
Mr. & Mrs. Gregory
George Tallas
Mr. Bruce K. Tammen &
Dr. Esther M. Menn
Mr. Ted Tanaka
Ms. Brenda Tarbell
Ms. Anna Tasiopoulos
Mr. Trevor Tay
Team Penguins
Mr. Edward Teel Jr.
Ms. Michelle R. Teggelaar
Mr. & Mrs. Earl H. Temkin
Ms. Tracey Terese
Terry Gebert Design Inc.
Ms. Lenora Thinnes
Mr. & Mrs. Robert
W. Thomas
Mr. William Thomas
Michelle Thompson
Mr. & Mrs. Ronald
R. Thompson
Thomson-West
Mr. J. Randall Thrall
Ms. Rhoda Thrall
Ms. Lakisha Tidwell
Ms. Linda Tidwell
Mr. Donald H. Tieri
Mr. & Mrs. Glenn R. Tilles
Tix 4 Causes, LLC
Ms. Dorothy A. Tobuch
Mr. & Mrs. Steven Topel
Mr. Manny Torres
William Towle
Mr. Mark Toyama
Tranter Family Trust
Ms. Traci L. Trapp
Mr. Jesse Trevino
Mr. & Mrs. Patrick Troy
Truist
Mr. Jerry Tscherrt Hunt
Mr. Robert E. Tucker II
Ms. Laura Tucker
Mr. & Mrs. Anthony
J. Turner
Ms. Stacey L. Turner
Ms. Eleni Tzotzolis
Mr. Konstantinos Tzounos
U.S. Bancorp Foundation
The U.S. Charitable
Gift Trust
Mr. & Mrs. Timothy
H. Ubben
Dr. Mary T. Uckerman
Mrs. Johanna R.
Ugo-Conlon
Mr. Pio D. Uliassi
Union Bank of Switzerland
United Way of
Mr. David Ureel
Ms. Patricia A. Vacilek
Mr. & Mrs. Joseph
M. Valerio
Van Cleff & Arpels, Inc.
Mr. Bernard Vance
Mrs. Lorraine Vandenbergh
Frances Vandervoort,
CER’82, SB’57, SM’65
& Peter Vandervoort,
AB’54, SB’55,
SM’56, PHD’60
Ms. Marilyn K. Vanucci
Mr. & Mrs. Nemesio
P. Vargas Jr.
Dr. Monica B. Vela
Mr. & Mrs. Dennis
C. Verenski
Mr. Randolph K. Vest
Mr. & Mrs. Robert
Von Halle
Mr. & Mrs. Kenneth
Von Schnase
Mr. Kenneth Von Schnase
Ms. Karishma Vora
Mr. Ralph D. Voris
Mr. Matthew Vuckov
Ms. Leslie J. Wadsworth
Mr. & Mrs. Daniel Waechter
Ms. Theresa M. Walczak
Ms. Janet Waldman
Mr. Harold Waldron Jr.
Ms. Amy A. Walker
Ms. Lorraine B. Walker
Joseph Wallace
Ms. Linda J. Wallace
Mrs. Judith Wallis
Ms. Judith A. Wallock
Mr. Christopher Walsh
Ms. Jennifer Walter
Ms. Marcia Walz
Mr. Edward Wanyandeh
Mr. & Mrs. Wayne
D. Warburton
Mr. & Mrs. John Ward
Mr. George Washington
Ms. Margaret Y. Waterman
Ms. Margaret Watson
Ms. Karen Watson-Goddard
Mr. & Mrs. Roland Wattman
Mr. Howard Wax
Mr. & Mrs. Harold Weaver
Mr. & Mrs. Ralph Weaver
Mr. & Mrs. Gregory
M. Weber
Mr. Seth Weinberger &
Ms. Barbara Goodman
Mr. & Mrs. Michael Weinger
Mr. Samuel Weinstein
Mr. Harvey A. Weiss
Dr. Roy Emanuel Weiss
& Ms. Fay Weiss
Rabbi Victor H.
Weissberg, DHL, DD
Mr. Bill Weldon
Ms. Linda Welton
Mrs. Virginia R. Wendt
Mr. & Mrs. Robert Werner
Ms. Bernadette Westberg
Mr. & Mrs. Mark Westcott
Ms. Maureen E. Westhoff
Westlake Motors LTD
Mr. Sydney L. Weydemeyer
Whalen Family Trust
Mr. & Mrs. William White
Mr. & Mrs. John A.
Whittemore
Mr. Edward E. Wicks
& Mrs. Maralee
Sabath Wicks
Ms. Betsy Widdop
Ms. Andrea E. Widen
Mr. Robert Wiedeman
Ms. Lindsay Wilde
Mr. Daniel L. Williams
Ms. Donna Jean Williams
Mr. & Mrs. Scott Williams
Mr. Herbert Williams
Ms. La Ronnia D. Williams
Ms. Rosetta Williams
Mr. & Mrs. Jonathan
F. Williams
Mr. William J. Willis
Ms. Margaret C. Wilson
Mr. Harvey S. Wineberg
Dr. & Mrs. Jerome A. Winer
Mr. & Mrs. Ron Winkler
Mr. Lynn G. Wodder &
Ms. Eileen Wodder
Mr. & Mrs. Jerrold
Emil Wolf
Mrs. Karel L. Wolfson
Ms. Patricia A. Wolsfelt
Mrs. Roycealee J. Wood
Ms. Alma Woodward
Mr. Chester Wright
David Yeager, MBA’88
Ms. Eileen Yedlin
Dr. & Mrs. Frederic
D. Young
Ms. Michelle Younghouse
Mr. Z.R. Zaccone Sr.
Mr. Mark Zancanaro
Ms. Toni Zaro
Ms. Katherine Zellmer
Mr. Bruce M. Zessar
Mr. Robert O. Zillmer
Mr. Douglas H. Ziminski
Mr. Karl R. Zimmer III
Mr. & Mrs. William
Zimmerman
Mr. & Mrs. Jerrold
R. Zisook
Mr. & Mrs. Clifford J. Zosso
Mr. Robert J. Zotti
Mr. John Zownorega
Ms. Alicia Zukowska
Ms. Shelley E. Zuraw
Mrs. Leon E.
Zygmun
* Deceased
The UCCCC is enormously grateful for the generous, unwavering commitment of our contributors. Every effort was made to ensure the accuracy of
this publication. Notification of errors or omissions should be made to:
Marilyn Duran
5841 S. Maryland Ave., MC1140, H212
Chicago, IL 60637-1470
38
Phone: 1-773-702-6566
Fax: 1-773-834-7855
[email protected]
cancer.uchicago.edu
2010 – 2011 Financial Report
At a challenging time for medical research
philanthropy, the UCCRF has raised more than
$2 million in the name of cancer research for the
6th consecutive year. We are pleased that while
we have taken on additional third-party fundraising groups, we have controlled expenses.
Beginning Balance
Fiscal prudence has protected us from the
economic downturn and permitted us to
support over 30 major basic and clinical
research projects again this year.
$ 2,425,367
Income
Income
UCCRF Contributions
$
397,400
UCCRF Capital Campaign
$
479,976
Boards/Auxiliaries
$ 1,196,299
Women’s Board Campaign
$
45,011
Endowment Income $
81,111
Total Income
$ 2,199,797
Boards/Auxiliaries
54.4%
UCCRF Capital Campaign
21.8%
UCCRF Contributions
18.1%
Expenses
Endowment Income
3.7%
Operating*
Personnel
$
308,222
Services
$
358,907
Supplies
$
5,103
$
672,232
Woman’s Board Campaign
2.0%
Expenses
Allocations
Research & Faculty Support
$
209,517
Women’s Board
$
540,000
Auxiliary Board
$
102,000
Associates Board
$
20,000
Capital Campaign
$
597,000
$ 1,468,517
Total Expenses /Allocations
$ 2,140,749
Ending Balance
$ 2,484,415
Allocations
68.6%
Operating
31.4%
* Period from 7/1/10 - 6/30/11
39
A Look ahead
We are very pleased to share with you our accomplishments
of 2010-2011. We are even more excited about the promise
for a future where many of cancer’s complexities will be
unraveled to enable earlier, more precise diagnoses, more
targeted treatments, and more comprehensive care for the
increasing number of survivors and their families.
Upholding the highest standards of excellence, innovation,
and collaboration, the UCCCC will continue to undertake
the bold initiatives that have led to many of the novel
treatments that have become today’s standard of care.
We envision a future where cancer is no longer a leading
cause of death in many populations, but a set of illnesses
that can be modified, managed, or even prevented.
40
cancer.uchicago.edu
Help Make Today’s Science Tomorrow’s Standard of Care
To make a donation or to learn more about how you can help our researchers explore
new ways to diagnose and treat malignant disease, contact The University of Chicago
Cancer Research Foundation (UCCRF) Executive Director Mary Ellen Connellan:
Online: cancer.uchicago.edu/donations
Phone:
1-773-834-7490
E-mail:
[email protected]
Mail:
The University of Chicago Cancer Research Foundation
5841 S. Maryland Ave., MC1140, H212
Chicago, IL 60637
The UCCRF is a not-for-profit 501(c)(3) organization. Federation Tax Identification
Number 36-6056201. All gifts are tax deductible as provided by law.
Comprehensive Cancer Center
Follow us:
Director, UCCCC; Arthur and Marian
Edelstein Professor of Medicine; Director,
Cancer Cytogenetics Laboratory
Today’s Science …
Tomorrow’s Standard of Care
Marcy A. List, PhD
Associate Director for Administration, UCCCC;
Scientific Director, Cancer Clinical Trials Office
Marsha R. Rosner, PhD
Deputy Director for Basic Sciences, UCCCC;
Charles B. Huggins Professor and Chair, Ben
May Department for Cancer Research
Richard L. Schilsky, MD
Deputy Director for Clinical Sciences,
UCCCC; Professor of Medicine; Section
Chief, Hematology/Oncology
Habibul Ahsan, MBBS, MMedSc
Associate Director for Population Research,
UCCCC; Professor of Health Studies,
Medicine, and Human Genetics
Geoffrey L. Greene, PhD
Associate Director for Basic Sciences and Education,
UCCCC; Virginia and D.K. Ludwig Professor and Vice
Chair, Ben May Department for Cancer Research;
Co-Director, Ludwig Center for Metastasis Research
Yves Lussier, MD*
Associate Director for Biomedical Informatics,
UCCCC; Associate Professor of Medicine;
Director, Center for Biomedical Informatics
Mark Ratain, MD
Associate Director for Clinical Sciences, UCCCC;
Leon O. Jacobson Professor of Medicine; Director,
Center for Personalized Therapeutics
Executive and Managing
Editor: Natalie Boden
(From left) UCCCC Associate Director Marcy List, PhD, Co-Deputy
Director Marsha Rosner, PhD, Director Michelle Le Beau, PhD, and
Co-Deputy Director Richard Schilsky, MD.
Karen E. Kim, MD, MS
Director, UCCCC Office of Community Engagement and
Cancer Disparities; Associate Professor of Medicine
Contributors: Mary Ellen Connellan, MA
Jane Kollmer
Cassie Simon, CTR
Wendy Stock, MD
James W. Vardiman, MD
Design: Brierton Design
Printer: G Thomas Partners
James Schilling, PhD
Associate Director for Core Facilities, UCCCC;
Director, Office of Shared Research Facilities
Natalie Olinger Boden
Director, Communications and Public Relations
Mary Ellen Connellan, MA
Executive Director, The University of
Chicago Cancer Research Foundation
Rajan Gopalakrishnan, MS
Director, Informatics
Hoyee Leong, PhD
Director for Scientific Communications
and Strategic Partnerships
Christine Miller, MA
Director, Finance
Consuelo Skosey, RN, CCRP
Director, Clinical Research Operations; Technical
Director, Cancer Clinical Trials Office
* Dr. Lussier left UChicago in August 2011.
© 2011 by The University of
Chicago Comprehensive Cancer
Center. All rights reserved.
At t h e F o r e f ro n t o f D i s c ov e ry®

Annual Report 2011 - The University of Chicago Medicine

Transcription

Similar documents

CNTEAEDITION2Newsletter - Colts Neck Township Education

Important Dates First in Math - Clark

Learning out of class…

open morning 27th June shaun.indd

Gay man`s wife reels from news

rolling knolls rockets

May 8 - Thunder Bay Christian School

January 20, 2012 - Urbana City Schools

The New York Herald-Tribune

mountain view news - Almadina Language Charter Academy